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Hypocalcaemia is the most common complication following thyroid surgery. It is associated with significant short and long-term patient morbidity. Many studies have assessed and reported on risks, predictive and preventative factors for post-operative hypocalcaemia. The aims of this research were to search the literature for useful preventative measures of post-thyroidectomy hypoparathyroidism and to assess two novel modalities for their potential in the early intraoperative identification and preservation of parathyroid glands to avoid postoperative hypocalcaemia.
The objectives of the study were:
1- To perform a systematic review and meta-analysis of the effectiveness of preventative and other surgical measures on post-thyroidectomy hypocalcaemia.
2- To study Methylene Blue (MB) emitted fluorescence from soft tissue structures in the rabbit neck thereby examining its potential for use in human surgery to differentiate between thyroid and parathyroid glands.
3- To determine the electrical impedance patterns of the thyroid, parathyroid and other soft tissue structure in the rabbit neck thereby examining the potential of impedance spectroscopy as an intraoperative tool for parathyroid identification.

Methods
Systematic review and meta-analysis: A comprehensive search of PubMed, EMBASE, and Cochrane databases was performed for studies reporting on preventative and other surgical measures and their  effect on reducing post-thyroidectomy hypoparathyroidism. Quality of included papers was assessed using the Cochrane risk of bias tool or a modified Newcastle-Ottawa Scale (NOS). The results of all included studies were summarized and meta-analyses were performed where appropriate. 
Two animal experiments were then carried out to assess the potential role of two novel modalities, near-infrared (NIR) fluorescence imaging using intravenous (IV) MB and electrical impedance spectroscopy (EIS), in the prevention of post-operative hypocalcaemia.
Near-infrared (NIR) fluorescence imaging using intravenous MB: Thyroid and external parathyroid glands (PGs) were exposed in six New Zealand White (NZW) rabbits under anaesthesia. Varying doses of MB (0.025 - 3 mg/kg) were injected through the marginal ear vein. NIR fluorescence from exposed tissues was recorded at different time intervals (0 - 74 minutes) using Fluobeam®700 device.
Electrical Impedance Spectroscopy (EIS): The central neck compartment was dissected in nine freshly culled NZW rabbits. In vivo and ex vivo electrical impedance (EI) were measured from thyroid lobes, external PGs, adipose tissue and strap muscle using APX100TM device.
The glands identified in these experiments were resected and sent for histological assessment.
Results
Systematic review and meta-analysis: This included 39 randomised controlled trials (RCTs) and 37 observational studies. Interventions studied included; haemostatic techniques, extent of thyroidectomy and central neck dissection, surgical approach, supplements (calcium, vitamin D and thiazide diuretics), parathyroid gland auto-transplantation (PGAT) and intra-operative parathyroid gland (PG) identification, truncal ligation of inferior thyroid artery (ITA), pre-operative magnesium infusion, and use of magnification loupes and surgicel.
Measures associated with significantly lower rates of transient hypocalcaemia in meta-analysis were: post-operative calcium and vitamin D supplementation compared to either calcium supplements alone (odds ratio (OR) 0.66; p=0.04) or no supplements (OR 0.34; p=0.007), and bilateral subtotal thyroidectomy (BST) compared to Hartley Dunhill (HD) procedure (OR 0.35; p=0.01). Meta-analyses did not demonstrate any measure to be significantly associated with a reduction in permanent hypocalcaemia.
NIR fluorescence: Thyroid and external PGs were the only neck structures to demonstrate significant fluorescence in the central neck compartment. External PGs demonstrated lower fluorescence intensities and reduced washout times at all MB doses compared to the thyroid gland. A dose of 0.1 mg/kg MB was adequate to identify fluorescence; this also delineated the blood supply of the external PGs.
EIS: The impedance was higher for thyroid tissue at lower frequencies and for parathyroid tissue at higher frequencies. Ex vivo electrical impedance spectra were significantly higher compared to the in vivo spectra across all frequencies for thyroid and parathyroid tissues (p < 0.001). The ratio of low to high frequency in vivo impedance of thyroid, parathyroid and muscle was significantly different (p < 0.001), allowing for differentiation between these tissues.
Histology confirmed correct identification of all excised thyroid and PGs in both experiments.

Conclusion
The systematic review identified post-operative calcium and vitamin D supplementation and bilateral subtotal thyroidectomy (over HD) as being effective in prevention of transient hypocalcaemia. However, the majority of RCTs were of low quality, primarily due to lack of blinding.
The wide variability in study design, outcome definitions and assessment methods prevented meaningful summation of results from studies on a number of preventative measures and for permanent hypocalcemia.
NIR fluorescence with IV MB helps to differentiate between thyroid and PGs in the rabbit. This has the potential to improve outcomes in thyroid and parathyroid surgery by increasing the accuracy of parathyroid identification. The use of low doses of MB may also avoid the side effects associated with currently used doses in humans (3-7mg/kg).
Electrical impedance spectra of rabbit thyroid and parathyroid glands are distinct and different from each other and from skeletal muscle. If these results are replicated in human tissue, they have the potential to improve patient outcomes by achieving early identification and preservation of PGs.
1. Introduction

Thyroid and parathyroid surgery are the most commonly performed endocrine procedures for both benign and malignant pathology. However these procedures do carry a risk of post-operative complications with both short and long-term effects on patients. The most common complication is post-operative hypocalcaemia with long-term detrimental effects on other body systems such as the cardiovascular, renal and nervous systems. Inadvertent devascularisation and/or removal of the parathyroid glands are the most likely causes; resulting in diminished or inadequate production of parathyroid hormone (PTH). Due to the scale and impact of this problem on patients’ health, researchers have been studying predictive and preventative methods to improve patients' outcomes.









1.1.1. Anatomy and Physiology

The thyroid gland consists of two lobes and is located in the neck (Figure 1.1.). It regulates the rate of metabolism and influences the development and function of other organs in the body (Figure 1.2.). Its function is regulated by a negative feedback loop mechanism known as “the hypothalamo-pituitary-thyroid axis” (HPT axis; Figure 1.3.).


Figure 1.1. Thyroid and Parathyroid glands anatomy ()


Figure 1.2. Thyroid gland function ()		Figure 1.3. HPT axis ()

The thyroid gland can be affected by a wide spectrum of benign, neoplastic and autoimmune diseases. Thyroid gland enlargement is commonly known as “goitre”, derived from the French word “goitron” originating from Latin “guttur” for throat, first used in 1625. Thyroid disease is more common in iodine deficient areas such as South-East Asia, Latin America and Central Africa  ADDIN EN.CITE (). When daily iodine intake is <50 mcg, goitre is usually endemic, and when it is <25 mcg, congenital hypothyroidism also becomes more common  ADDIN EN.CITE ().

1.1.2. Epidemiology and clinical presentation of thyroid disease

The most prevalent thyroid condition is physiological goitre when thyroid hormone requirements are increased such as during puberty, pregnancy, and lactation  ADDIN EN.CITE (). Another variant is nodular goitre, which can present either as a solitary or multiple nodules. Incidence of asymptomatic nodular goitre is under reported as more fine thyroid nodules are picked up incidentally on neck ultrasonography which is more sensitive than clinical examination  ADDIN EN.CITE ().

Hypothyroidism refers to an under-active thyroid gland, which occurs spontaneously in 1-2% of the population with a 10:1 female to male ratio  ADDIN EN.CITE (). Studies in Europe, Japan and the USA have reported annual incidence of hypothyroidism of 0.6-12/1000 for women and 1.3-4/1000 for men with higher incidence in the elderly population  ADDIN EN.CITE (). Reported annual incidence in the UK is similar; where the incidence rates are 3.5/1000 & 0.6/1000 women and men respectively. Approximately 8% of women and 3% of men have subclinical hypothyroidism (i.e. raised TSH with normal T4) (). Symptoms of hypothyroidism include: fatigue, lethargy, weight gain, depression, bradycardia, and intolerance to cold. The treatment of symptomatic hypothyroidism is with thyroxine hormone replacement.

Hyperthyroidism reflects an over-active thyroid gland, commonly due to Graves’ disease, or toxic multinodular goitre, and rarely due to a solitary toxic thyroid adenoma or thyroiditis  ADDIN EN.CITE (). Similar to hypothyroidism, hyperthyroidism is ten times more common in women compared to men  ADDIN EN.CITE ().The Whickham survey reported a mean annual incidence of hyperthyroidism to be 0.8 per 1000 women with no new cases diagnosed in men in the same time period when the survey was carried out  ADDIN EN.CITE (). Symptomatic patients usually present with; weight loss, increased appetite, tremors, intolerance to heat, irritability, anxiety, and palpitations. Rarely, patients present with what is known as “thyroid storm”: temperature >40 degrees Celsius, tachycardia, arrhythmias, vomiting, and diarrhoea. Thyrotoxic crisis warrants emergency admission, and patients are treated with anti-thyroid drugs and beta-blockers.
 
A recent epidemiology survey in Tayside in Scotland revealed that the overall prevalence of thyroid dysfunction has increased from 1994 to 2001(). An annual increase of 7.4% in women and 7.6% in men for hypothyroidism; and 5.5% in females and 5.4% in males for hyperthyroidism was reported (). Management of hyperthyroidism is more complicated; anti-thyroid drugs are initially required and surgery or radio-iodine for patients with persistent/severe disease or relapse.

Thyroid cancer is the most common endocrine tumour worldwide representing >90% of all endocrine cancers and about 1% of all cancers diagnosed in the UK (). Thyroid cancer, when diagnosed early, presents as a solitary thyroid nodule or an increase in goitre size. In advanced cancers, it manifests as hoarseness, compression symptoms or enlarged cervical lymph nodes. Cancer Research UK reported a rise in the annual incidence of thyroid cancer from 2008 of 5.1/100,000 in women and 1.9/100,000 in men, mostly due to the increase in the diagnosis of papillary thyroid cancer ≤2cm  ADDIN EN.CITE ().

1.1.3. Surgical management of thyroid disease

Indications for thyroid surgery vary according to the nature of the disease involved, and can be broadly classified as follows: suspected or confirmed malignancy (papillary, follicular and medullary), progressively enlarging goitre (especially with compression symptoms), toxic goitre (especially after failed medical therapy, young patients or progressive eye symptoms, women who wish to be pregnant) and in large goitre without compression for cosmesis or undue anxiety ().
 
Thyroid surgery can be broadly divided into two main categories, unilateral and bilateral resection. Unilateral surgery or “hemithyroidectomy/lobectomy” involves resection of one entire lobe together with the thyroid isthmus and is usually done in benign diseases limited to one lobe. Bilateral thyroid surgery includes many subtypes and often local practice and surgeon’s preference plays a role in deciding which procedure to perform. Bilateral surgery includes BST/ST (bilateral subtotal thyroidectomy, leaving behind 3-5gm of thyroid tissue on each side), NT (near-total thyroidectomy leaving a remnant of tissue on one or both sides in close proximity to the recurrent laryngeal nerve (RLN); the amount of tissue left behind being very variable), Hartley Dunhill procedure (hemi-thyroidectomy and subtotal resection on the other side), and TT (total thyroidectomy). Since the 1990s, NT & TT have been increasingly preferred for both malignant and benign pathology due to negligible risk of disease recurrence and similar morbidity when compared to less extensive surgery  ADDIN EN.CITE ().

The most common complication following thyroid surgery is post-thyroidectomy hypocalcaemia, which can be either temporary (incidence ranging from 2-50%)  ADDIN EN.CITE () and/or permanent (incidence ranging from 0.3-13.8%)  ADDIN EN.CITE (). Other complications include: recurrent laryngeal nerve (RLN) injury, bleeding, wound infection, injury of the external laryngeal nerve, and recurrent disease.

1.2. Parathyroid Gland
1.2.1. Anatomy and Physiology

Parathyroid glands (PGs) are small endocrine glands, weighing approximately 30-40mg each, which can vary in number and location  ADDIN EN.CITE (, ).They are usually four in number, described as superior and inferior glands on each side, where the superior PGs originate from the fourth and the inferior PGs from the third pharyngeal pouches (). They play a central role in calcium metabolism in the body through a complex feedback mechanism involving parathyroid hormone (PTH), serum ionised calcium and vitamin D. Calcium-sensing receptors (CSRs), which are located on the surface of the parathyroid chief cells (and also present in the kidneys and gastrointestinal tract), are able to detect minor changes in serum levels of extracellular ionised calcium. When serum calcium levels drop, the CSRs are activated thereby stimulating the synthesis and release of PTH by the parathyroid glands. PTH acts on the proximal renal convoluted tubules increasing both calcium resorption and the hydroxylation of 25-hydroxy vitamin D to the biologically active 1,25-dihydroxy vitamin D; the latter promotes calcium absorption in the small intestine and helps maintain healthy bone. PTH also acts on bone by stimulating the osteoclast activity leading to bone resorption and increased serum calcium levels.

1.2.2. Epidemiology and clinical presentation of parathyroid disease

Hyperparathyroidism is the most common disease affecting PGs and can be classified into three categories: Primary hyperparathyroidism (PHPT) when the PGs become autonomously overactive, secondary mainly due to chronic renal failure and vitamin D deficiency, and tertiary (​http:​/​​/​en.wikipedia.org​/​wiki​/​Tertiary_hyperparathyroidism" \o "Tertiary hyperparathyroidism​) in patients with severe chronic secondary hyperparathyroidism where chronically stimulated parathyroid glands become autonomous ().

PHPT can be due to a solitary active adenoma, hyperplasia affecting one or more glands, or rarely carcinoma. In primary cases, approximately 50% of patients are asymptomatic and are usually diagnosed incidentally  ADDIN EN.CITE (). Symptoms, although non-specific, include; weakness, fatigue, depression, nausea, vomiting, polyuria, polydipsia, nephrolithiasis, osteoporosis, and fractures. Jorde et al., (2000) carried out a large health survey in an outpatient setting as a screening service (). This study included a large patient sample of various age groups and backgrounds, which reflects a good study design increasing the generalisability of its results. All patients with calcium levels equal to or higher than the upper limit of normal (i.e. ≥2.6 mmol/L) were followed up in the outpatient department. 282 patients were diagnosed with biochemical PHPT and were followed up for 3 years with no losses to follow-up increasing the reliability of their results. It showed that prevalence of PHPT was higher in women and increased with age, but disease progression was minimal and very slow. 
A recent epidemiological study in the US estimated the mean prevalence of PHPT to be 66/100,000 in women and 25/100,000 in men with increased incidence in females over the age of 50 in a large mixed population  ADDIN EN.CITE (). National surveys in the US reported 83 deaths in 2005 to be related to hyperparathyroidism and other PG disorders mostly due to cardiovascular morbidity  ADDIN EN.CITE (). 

Hypoparathyroidism is associated with underproduction of PTH and the subsequent drop in serum calcium levels. It is usually encountered following thyroid and parathyroid surgery in >75% of cases (), or rarely due to autoimmune infiltration and destruction of the PGs or haemochromatosis. Hypoparathyroidism is managed medically with oral calcium and vitamin-D supplements. 

Parathyroid carcinoma is a rare disease, difficult to diagnose and responsible for <1% of all hyperparathyroidism cases with no predilection to age, gender, race or geographical distribution  ADDIN EN.CITE (, ). Increased incidence of parathyroid cancer can be explained by the increase in patient referrals, increased number of patients undergoing parathyroid surgery and the improvement in immunohistochemistry diagnostic techniques such as parafibromin and protein gene product 9.5 (). The only definitive treatment for parathyroid carcinoma is surgical excision  ADDIN EN.CITE (, ).

1.2.3. Surgical management of parathyroid disease

Hedbäc (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Hedb%C3%A4ck%20G%5BAuthor%5D&cauthor=true&cauthor_uid=14713275​)k et al., (1991) followed up all 896 patients operated for PHPT between 1953 and 1982 to assess survival rates and quality of life (). This study aimed to evaluate the risk of persistent disease following multiple operations in order to achieve cure. Patients with total serum calcium > 2.55 mmol/L were further evaluated and their medical notes assessed. All patients who were cured following surgery and those who had early surgery, had significantly better health and lower risk of early death compared to patients with persistent disease (). Guidelines on when to operate on patients with mild asymptomatic PHPT include; serum calcium maintained at > 0.25 mmol/L above the upper normal limits; reduced bone density (T score < -2.5) at lumbar spine, total hip, femoral neck or distal third of radius; evidence of vertebral fracture by x-ray, CT or MRI; creatinine clearance < 60 ml/min; 24-hour urine calcium > 10 mmol/dL with increased stone risk by the biochemical stone risk analysis; presence of nephrolithiasis or nephrocalcinosis by x-ray, ultrasound or CT and patients younger than 50 years of age  ADDIN EN.CITE (). Although the management of secondary hyperparathyroidism is predominately medical, about 1-2% of patients still require parathyroidectomy each year for the following indications; calciphylaxis, hypercalcaemia, hyperphosphataemia, patient preference, failed medical therapy, osteoporosis and PTH > 800 pg/ml (). In contrast, tertiary hyperparathyroidism is mostly treated by surgery and is indicated in cases with: severe hypercalcaemia (total calcium > 4 mmol/L), osteoporosis, symptomatic patients (fatigue, pruritis, bone pain, pathological bone fracture, renal stones), peptic ulcer disease and mental status changes ().
 
Parathyroidectomy has evolved significantly over the last 15 years, especially with pre-operative radiological localisation (e.g. Sestamibi scan). There has been a shift from the more invasive bilateral neck exploration to limited exploration also known as focused or targeted parathyroidectomy (). Limited exploration is associated with shorter operative time, day surgery admission and improved cost-effectiveness  ADDIN EN.CITE (). Primary hyperparathyroidism is the main indication for parathyroid surgery. The underlying pathology is primarily parathyroid adenoma (80-90%, usually single gland disease) (); less commonly due to hyperplasia (5-15%, multiple gland disease) (); and rarely due to malignancy (<1%)  ADDIN EN.CITE (, ). 

Challenges associated with parathyroid surgery include failure to cure due to under-treatment, and the likelihood of hypocalcaemia with over treatment  ADDIN EN.CITE (). Postoperative hypocalcaemia following subtotal to total parathyroidectomy for secondary and tertiary hyperparathyroidism may affect as much as 15-30% of patients (). Severe (requiring urgent admission and intravenous calcium replacement) or permanent hypocalcaemia with long-term calcium and vitamin D supplementation is estimated to affect up to 7% of patients (). Other complications include RLN injury. Accelerated bone remineralisation (also known as "hungry bone syndrome") may also cause hypocalcaemia unrelated to parathyroid insufficiency.

Although bilateral neck exploration remains the gold standard in many centres  ADDIN EN.CITE (, ), minimally invasive scan-directed approaches are increasingly being adopted  ADDIN EN.CITE (). Early and accurate identification of normal and/or enlarged parathyroid glands assists in reducing the extent of surgical dissection, which could decrease the chances of postoperative hypocalcaemia.

1.3. Postoperative hypocalcaemia
1.3.1. Scale and Impact

Postoperative hypocalcaemia is the most common complication following thyroid and parathyroid surgery. Many mechanisms could explain its aetiology. These include inadvertent damage, removal and/or devascularisation of PGs, co-existing vitamin D deficiency, haemodilution and hungry bone syndrome ().  The definitions of transient and permanent hypocalcaemia vary significantly according to local practice and some examples are illustrated in the following table  ADDIN EN.CITE ():

Table 1.1. Examples of definitions of Transient and Permanent Hypocalcaemia used in different studies
Transient Hypocalcaemia	Permanent Hypocalcaemia
Serum Ca <2.1 mmol/L in the first 2 weeks postop ()	Needing Ca & vitamin-D replacement lifelong ()
Serum Ca <2.1 mmol/L with abnormal PTH  ADDIN EN.CITE ()	Needing Ca replacement at 1 year postop  ADDIN EN.CITE ()
Adjusted Ca <2.0 mmol/L or symptomatic ()	
Adjusted Ca <8 mg/dL with low PTH  ADDIN EN.CITE ()	Persistent 1 year after surgery  ADDIN EN.CITE ()
Needing Ca supplements to maintain normal serum Ca or to prevent symptoms ()	Persistent 1 year after surgery ()
Adjusted Ca <1.7 mmol/L or symptomatic for TT  ADDIN EN.CITE (, )	Lasting > 6 months  ADDIN EN.CITE (, )
Adjusted Ca <1.7 mmol/L or symptomatic for TT/ST ()	Needing supplements for > 6 months ()

Symptoms and signs of hypocalcaemia include circumoral paraesthesia, mental changes, tetany, carpopedal spasm and laryngospasm. This can be treated effectively with calcium and/or vitamin D supplements, which may lead to troublesome long-term effects on kidneys such as nephrocalcinosis or deposition of calcium-phosphate salts in soft tissues  ADDIN EN.CITE (, ).
Management of hypoparathyroidism still poses a challenge to the treating physicians and a burden to the healthcare system. Calcium and vitamin D replacement therapy has been associated with over-treatment leading to hypercalcaemia, which increases the risk of nephrolithiasis and impaired renal function  ADDIN EN.CITE (). Mitchell et al., (2012) followed up the course of the disease in a large cohort of 120 patients with hypoparathyroidism of various aetiologies, predominantly postsurgical  ADDIN EN.CITE (). Patient presentations included symptomatic hypocalcaemia (seizures in 8% of patients following diagnosis and starting treatment), symptomatic hypercalcaemia, nephrocalcinosis, dilated cardiomyopathy attributed to prolonged hypocalcaemia and basal ganglia calcification documented on brain imaging. The long-term morbidity highlights the need for exploring novel surgical and other modalities to reduce the risk of  post surgical hypoparathyroidism.

1.3.2. Predictor factors for postoperative hypocalcaemia

Various predictors for post-operative hypocalcaemia have been reported in literature. These can be broadly classified into biochemical and non-biochemical factors. Non-biochemical factors include female gender, parathyroid auto-transplantation, number of PGs identified intra-operatively, Graves' disease, weight of thyroid specimens, inadvertent PG excision, recurrent disease, re-operation for bleeding, duration of surgery and postoperative wound infection.
Biochemical markers include pre-operative calcium, peri-operative PTH, pre-operative 25-vitamin D and postoperative magnesium. These risk factors can alert clinicians to patients who are at more risk of developing hypocalcaemia, and enable appropriate management.
The author of this report contributed to a recently published comprehensive systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia (). This report identified the following as significant predictors of postoperative hypocalcaemia: Independent predictors of transient hypocalcaemia included levels of preoperative calcium, peri-operative PTH, preoperative 25-hydroxyvitamin D and postoperative magnesium. Clinical predictors included surgery for recurrent goitre and reoperation for bleeding. A calcium level lower than 1·88 mmol/l at 24 h after surgery, identification of fewer than two parathyroid glands (PTGs) at surgery, reoperation for bleeding, Graves’ disease and heavier thyroid specimens were identified as independent predictors of permanent hypocalcaemia in multivariable analysis. Factors associated with transient hypocalcaemia in meta-analyses were inadvertent PTG excision (odds ratio (OR) 1·90, 95 per cent confidence interval 1·31 to 2·74), PTG auto-transplantation (OR 2·03, 1·44 to 2·86), Graves’ disease (OR 1·75, 1·34 to 2·28) and female sex (OR 2·28, 1·53 to 3·40).
 
1.3.3. Prevention of postoperative hypocalcaemia

Various preventative measures have been proposed to reduce the risk of postoperative hypocalcaemia. These include use of magnification loupes, modifying the extent of thyroid surgery and lymph node dissection, and the use of different haemostatic techniques. Several studies have suggested that less extensive surgery can decrease overall complication rates  ADDIN EN.CITE (, , ). Other studies have looked at dissection/haemostatic techniques (e.g. harmonic scalpel and ligasure). Other measures include PG auto-transplantation, surgical approach (open surgery versus endoscopic and video-assisted), supplementation therapy, inferior thyroid artery (ITA) ligation, loupe magnification, preoperative medications and the use of surgicel. The author of this report carried out a comprehensive systematic review and meta-analysis to fully assess the role of current preventative measures for postoperative hypocalcaemia, which is discussed in details in the following chapter.


2. Effectiveness of preventative and other surgical measures on hypocalcaemia following bilateral thyroid surgery: a systematic review and meta-analysis
2.1. Introduction

Hypocalcaemia is the most common complication following bilateral thyroid surgery  ADDIN EN.CITE (, ). Inadvertent damage or excision of parathyroid glands (PGs) or damage to their blood supply during thyroidectomy is the most common aetiology of hypocalcaemia  ADDIN EN.CITE (, ). Reported rates range from 5-35 % and 0.5-4.4 % for transient and prolonged hypocalcaemia respectively (). A Scandinavian multicentre register reported rates of 9.9 % and 4.4 % for transient and prolonged hypocalcaemia respectively  ADDIN EN.CITE (). The British Association of Endocrine and Thyroid Surgeons (BAETS) fourth national audit 2012 reported a median annual incidence of 24.2% and 12.1% for transient and prolonged hypocalcaemia respectively following bilateral thyroid surgery (). 

Features of hypocalcaemia include circumoral and peripheral paraesthesia, tetany, carpopedal spasm, laryngospasm, and echocardiogram (ECG) changes (). Cardiac arrhythmias and arrest can also occur in severe cases (). Long-term hypocalcaemia/hypoparathyroidism has a significant impact on the quality of life and results in patients being at a higher risk of chronic renal impairment and basal ganglia calcification  ADDIN EN.CITE ().

Various measures have been proposed to reduce the risk of postoperative hypocalcaemia. These include use of magnification loupes, modifying the extent of thyroid surgery and lymph node dissection, and the use of various haemostatic techniques. Several studies have suggested that less extensive surgery (i.e. subtotal thyroidectomy (ST) and near-total thyroidectomy (NTT) versus total thyroidectomy (TT)) can decrease overall complication rates  ADDIN EN.CITE (, , ). Despite this, there has been increased acceptance of TT as the operation of choice for both benign and malignant thyroid diseases due to lower risks of disease recurrence (). Other studies have looked at dissection/haemostatic techniques (e.g. harmonic scalpel and ligasure) and their effect on operative outcomes  ADDIN EN.CITE (). However the small numbers of patients studied and conflicting results limit the interpretation with regards to their effect on hypocalcaemia. Ecker et al., (2010) carried out a meta-analysis comparing harmonic scalpel versus other haemostatic techniques in thyroid surgery () and included RCTs only (total of 12). The quality of included RCTs was briefly discussed, but no formal assessment tool was used. The review reported on operating time, intra-operative blood loss, volume of drainage fluid and complication rates. Complications were reported collectively and included recurrent laryngeal nerve (RLN) palsy, hypoparathyroidism, seroma formation and haematoma. The rate of complications in the 'harmonic scalpel' arm was reported to be similar to other haemostatic techniques.

The objective of this study was to systematically assess available literature that report measures aimed to reduce transient and permanent hypocalcaemia rates following bilateral thyroid surgery. Due to the scarcity of high quality RCTs in this area, it was decided to include both RCTs and cohort studies in this review.

2.2. Methodology
2.2.1. Search strategy and study inclusion 

A comprehensive search of PubMed, Embase, and the Cochrane library databases was undertaken from 01/01/1990 to 31/12/2013 to identify studies reporting on measures to reduce hypocalcaemia following bilateral thyroid surgery. The following terms were used as free text in the search: “low calcium” OR “hypocalc*” AND “thyroi*”. All published original articles of observational or interventional design that reported on prevention of hypocalcaemia following bilateral thyroid surgery in humans were included. Reviews, letters/editorials, articles with fewer than 25 patients, irretrievable full-text articles, articles not available in English language, animal studies, single-arm studies, non-comparable groups, historical controls, wrong population (i.e. unilateral thyroidectomy), and articles published before 1990 were excluded. 

2.2.2. Population, interventions and outcomes 

Patients undergoing bilateral thyroidectomy (with or without lymph node dissection) for benign or malignant disease where both lobes were partly or completely removed were the focus of study. All measures introduced to prevent hypocalcaemia were considered for inclusion. Similarly, any study that reported on postoperative hypocalcaemia was included, regardless of the definitions used for transient or permanent hypocalcaemia.

2.2.3. Data extraction 





The quality scores of included studies and incidence of hypocalcaemia were reported as median and interquartile range (IQR). Observational studies were not included in the meta-analysis, but were described as part of the systematic review. The difference in quality between prospective and retrospective observational studies was assessed with the Mann Whitney U test. 

A meta-analysis was performed when there were 2 or more RCTs that evaluated the same measure. The meta-analysis was performed using the random effects model due to the variability in the populations, nature of preventative measures, hypocalcaemia definitions and the assessment methods of outcomes across the included studies. The meta-analysis is presented as odds ratio (OR) with 95 per cent confidence interval (CI) of the OR. The p value for chi-square test for heterogeneity, I2 statistic for the degree of heterogeneity across studies, and Forest plots illustrating the results of meta-analyses were obtained using Revman5 software. A rough guide to interpret “I2 statistic” for the degree of heterogeneity is as follows (): 0-40 per cent may not be important; 30-60 per cent may represent moderate heterogeneity; 50-90 per cent may represent substantial heterogeneity; and 75-100 per cent represent considerable heterogeneity.





























The study included 39 RCTs and 37 interventional cohort studies (Table 3.1.). The 39 RCTs had a median (IQR) score of 3 (2-3). Of the 37 cohort studies, 25 were retrospective and 12 were prospective. The 25 retrospective cohort studies had a median (IQR) quality score of 7 (6-8), and the 12 prospective cohort studies had a median (IQR) quality score of 5 (5-7). Quality scores were not significantly different between retrospective and prospective cohorts (Mann-Whitney U test; p = 0.124). Preventative measures included the extent of thyroid surgery and neck dissection, haemostatic technique, surgical approach, peri-operative administration of calcium, vitamin D, thiazide/magnesium supplements, use of magnification loupes, inferior thyroid artery (ITA) truncal ligation, parathyroid gland auto-transplantation (PGAT) and intra-operative PG identification.
Table 2.1. Characteristics of included studies
	RCT	Prospective cohort	Retrospective cohort
Number of studies	39	12	25
Transient hypocalcaemia	Defined = 27Implied = 5Not defined = 7	Defined = 7Not defined = 4Implied = 1	Defined = 19Implied = 1Not defined = 5
Permanent hypocalcaemia	Defined = 17Implied = 1Not defined = 21	Defined = 5Not defined = 7	Defined = 21Implied = 1Not defined = 3
Exclusion criteria	Mentioned = 32No mention = 7	Mentioned = 10No mention = 2	Mentioned = 15No mention = 10
High quality studies(RCT ≥ 5 ; cohort ≥ 6)	Yes = 4No = 35	Yes = 6No = 6	Yes = 21No = 4
Disease pathology	Benign = 15Mixed = 18Malignant = 4No mention = 2	Benign = 4Mixed = 5Malignant = 1No mention = 2	Benign = 8Mixed = 7Malignant = 10

Various parameters have been used to define transient and long-term/permanent hypocalcaemia in the included studies (Tables 2.2. and 2.3.). The level of calcium used to define transient hypocalcaemia in 48 studies is listed in Table 2.4., and the duration used to define permanent hypocalcaemia in 44 studies is listed in Table 2.5. Transient and long-term hypocalcaemia were not defined in 16 and 31 studies respectively.
Table 2.2. Parameters used to define “Transient Hypocalcaemia”
Parameter for “Transient Hypocalcaemia”	Number (total = 76)
Ca level	22
Ca level + symptoms 	16
Ca level + need for treatment	4
Ca level + symptoms + need for treatment	4
Symptoms	4
PTH level	2
Symptoms + need for treatment	1
Implied/unclear	7
Not defined	16
Table 2.3. Parameters used to define “Permanent Hypocalcaemia”
Parameter for “Permanent Hypocalcaemia”	Number (total = 76)
Ca level + duration	14
Ca level + need for treatment + duration	9
Need for treatment + duration	8
Symptoms + duration	4
Ca level + symptoms + duration	2
Ca & PTH level + need for treatment + duration	2
Duration alone	2
Serum iPTH + need for treatment + duration	2




The most common biochemical cut-off value used to define transient hypocalcaemia was total serum calcium < 2.0 mmol/L in 31 studies (Table 2.4.). Three studies used a combination of biochemical markers to define transient hypocalcaemia: total serum calcium < 2.0 mmol/L and/or ionised calcium < 1.0 mmol/L  ADDIN EN.CITE (, ), total serum calcium < 2.0 mmol/L and/or PTH < 15 pg/ml  ADDIN EN.CITE (). Besic et al,. (2008) defined transient hypocalcaemia as total serum calcium < 2.1 mmol/L, which resolved within six months (). The most common duration used to define permanent hypocalcaemia was ≥ 6 months in 32 studies (Table 2.5.).

Table 2.4. Calcium/PTH levels used to define "Transient Hypocalcaemia"
Ca level used to define Transient Hypocalcaemia	Number of studies (N = 51)
Serum Ca < 2.0 mmol/L	31
Serum Ca < 2.125 mmol/L	6

Serum Ca < 2.25 mmol/L	1
Ionised Ca < 1.0 mmol/L	4
Ionised Ca < 1.1 mmol/L	3
Ionised Ca < 1.8 mmol/L	1
Ionised Ca < 2.05 mmol/L	1
Serum PTH < 15 ng/L	2
Serum PTH < 10 pg/ml	1
Corrected Ca < 1.875 mmol/L	1


Table 2.5. Duration used to define "Permanent Hypocalcaemia"
Duration used to define Permanent Hypocalcaemia	Number of studies (N = 44)
≥ 6 months	32




2.3.1. Haemostatic techniques (Table 2.6.)

Four methods were studied including harmonic scalpel, ligasure, a novel BiClamp device and a new vessel sealer device “The Starion TLS2 vessel sealing system”. 
22 studies compared the harmonic system versus conventional haemostasis, three of which had 3 arms assessing harmonic and ligasure versus conventional techniques  ADDIN EN.CITE (, , ). A meta-analysis of 17 RCTs  ADDIN EN.CITE (, , , , , ) showed no significant effect on transient hypocalcaemia associated with the use of harmonic scalpel (Figure 2.2a.; OR 0.74; 95 per cent CI 0.47-1.16; p=0.19), and no significant effect on permanent hypocalcaemia (Figure 2.2b.; OR 0.35; 95 per cent CI 0.08-1.59; p=0.17). A recent multicenter observational study by Materazzi et al., comparing harmonic focus to clamp-and-tie haemostasis showed significantly lower rates of transient hypocalcemia associated with the harmonic device  ADDIN EN.CITE ().

Table 2.6. Haemostatic techniques and effect on post-thyroidectomy hypocalcaemia
Prevention studied (number of studies)	Control arm;  Study design	Transient Hypocalcaemia	Permanent Hypocalcaemia
Harmonic scalpel(N=22)	Conventional (knots, clips, diathermy);RCT = 16Pros cohort = 2Retro cohort = 1	Decreased risk: 4No effect: 16Increased risk: 1Significance not tested: 1	Decreased risk: 1No effect: 18Risk not assessed: 3
Ligasure(N=5)	Conventional;RCT = 2Pros cohort = 1Retro cohort = 3	No effect: 4Increased risk: 1	No effect: 4Risk not assessed: 1
Ligasure(N=1)	Harmonic scalpel;Retro cohort	No effect	No effect
BiClamp device(N=1)	Ligasure device;Pros cohort	Decreased risk	Risk not assessed
The Starion TLS2 vessel sealing system (N=1)	Conventional; RCT	No effect 	No effect 










Five studies compared ligasure with conventional techniques  ADDIN EN.CITE (, , , , ). None of the studies demonstrated any advantage of ligasure over conventional haemostasis (Table 2.6.). A meta-analysis of the two RCTs  ADDIN EN.CITE (, ) showed significant increase in transient hypocalcaemia with ligasure compared to conventional haemostasis (Figure 2.3.; OR 0.57; 95 per cent CI 0.10-3.13; p=0.51). Neither trial reported on permanent hypocalcaemia.
Scerrino et al., (2010) carried out a RCT comparing a new vessel sealer device “The Starion TLS2” to the clamp-and-tie technique; this demonstrated no effect on either transient or permanent hypocalcaemia (). Another prospective study compared a new BiClamp device with Ligasure, showing lower risk of transient hypocalcaemia in the former; permanent hypocalcaemia was not assessed  ADDIN EN.CITE (). Zarebczan et al. (2011) retrospectively compared harmonic scalpel to ligasure and found no significant differences between both devices on transient and permanent hypocalcaemia rates ().


Figure 2.3. Meta-analysis comparing Ligasure versus Conventional haemostasis (knot tying, clips and diathermy) on transient hypocalcaemia.


2.3.2. Extent of thyroid surgery (Table 2.7.)

Sixteen studies  ADDIN EN.CITE (, , , ) assessed the extent of thyroid surgery and its impact on post-operative morbidity including hypocalcaemia. Five studies compared NTT versus TT (control arm) in patients with multinodular goitre. Meta-analysis of 2 RCTs  ADDIN EN.CITE (, ) demonstrated no significant effect on transient hypocalcaemia associated with NTT (Figure 2.4.; OR 0.09; 95 per cent CI 0.00-1.69; p=0.11). However no patient developed permanent hypocalcaemia in either RCT.

Figure 2.4. Meta-analysis comparing Near-Total Thyroidectomy versus Total Thyroidectomy on transient hypocalcaemia.


For the purpose of this review, all procedures described as 'subtotal' resections were considered as a single group regardless of the extent of resection. Three RCTs compared bilateral subtotal thyroidectomy (BST) to Hartley Dunhill (HD) procedure (control) in treating patients with benign thyroid disease  ADDIN EN.CITE (). Meta-analysis demonstrated significantly lower rates of transient hypocalcaemia associated with ST (Figure 2.5a.; OR 0.35; 95 per cent CI 0.15-0.79; p=0.01), but no effect on permanent hypocalcaemia (Figure 2.5b.; OR 0.47; 95 per cent CI 0.07-3.29; P=0.45).








Four retrospective studies  ADDIN EN.CITE (, , , ) examined the role of TT versus subtotal thyroidectomy (control group) in treating benign thyroid disease. One study found that TT significantly increased the risk of transient hypocalcaemia (OR 5.4, 95 per cent CI 3.1-9.2) (), but recurrence rates were not reported. However, there was no increased risk of transient or permanent hypocalcaemia in the remaining studies in patients undergoing TT  ADDIN EN.CITE (, , ).





Table 2.7. Extent of Thyroid surgery and effect on post-thyroidectomy hypocalcaemia
Prevention studied (number of studies)	Control arm; Study design	Transient Hypocalcaemia	Permanent Hypocalcaemia
NTT(N=5)	TT;RCT = 2Pros cohort = 1Retro cohort = 2	Decreased risk: 3No effect: 2	No effect: 5
ST(N=7)	TT;RCT = 1Pros cohort = 1Retro cohort = 5	Decreased risk: 2No effect: 5	No effect: 7
HD(N=3)	ST;RCT = 3	No effect: 2Increased risk: 1	No effect: 3
HD(N=1)	TT;Retro cohort	No effect	No effect
TT(N=4)	ST;Retro cohort = 4	No effect: 2Increased risk: 1Risk not assessed: 1	No effect: 4
Note: NTT – near-total thyroidectomy; ST – subtotal thyroidectomy; HD – Hartley Dunhill procedure; TT – total thyroidectomy; Pros - prospective; Retro - Retrospective.


2.3.3. Extent of lymph node dissection (Table 2.8.)

The need for a prophylactic central compartment lymph node dissection remains a controversial issue in the management of patients with thyroid cancer without clinical or radiological evidence of cervical lymphadenopathy. A primary concern of doing a prophylactic central neck dissection (pCND) is the incidence of hypoparathyroidism. Six retrospective studies assessed the role of TT with pCND versus TT alone  ADDIN EN.CITE (). Three reported significantly higher rates of transient hypocalcaemia  ADDIN EN.CITE (, , ), and one reported significantly increased risk of permanent hypocalcaemia in patients undergoing pCND  ADDIN EN.CITE (). The three other studies showed no significant effect on either transient or permanent hypocalcaemia  ADDIN EN.CITE (, , ).

Son et al., (2008) and Lee et al., (2007) compared TT with ipsilateral pCND versus TT with routine bilateral pCND (control group) in management of papillary thyroid cancer (PTC)  ADDIN EN.CITE (, ). Both were retrospective studies and found that ipsilateral pCND was associated with significantly lower rates of transient hypocalcaemia and no effect on permanent hypocalcaemia. Raffaelli et al. (2012) compared the effect of TT with selective removal of enlarged lymph nodes (control group) versus TT with either routine ipsilateral or bilateral pCND (). TT with routine bilateral pCND was associated with significantly higher rates of transient, but not permanent hypocalcaemia.


Table 2.8. Extent of prophylactic Central Neck Dissection (pCND) and effect on post-thyroidectomy hypocalcaemia
Prevention studied (number of studies)	Control arm; Study design	Transient Hypocalcaemia	Permanent Hypocalcaemia
TT + pCND(N=6)	TT without pCND;Retro cohort = 6	No effect: 3Increased risk: 3	No effect: 5Increased risk: 1
TT + pretracheal, prelaryngeal & ipsilateral paratracheal CND (N=2)	TT + bilateral pCND;Retro cohort = 2	Decreased risk: 2	No effect: 2
TT + pCND + unilateral thymectomy(N=1)	TT + pCND + bilateral thymectomy;Retro cohort	Decreased risk	No effect
TT + ipsilateral pCND and TT + bilateral pCND (N=1)	TT +/- selective removal of enlarged central LNsPros cohort	Increased risk:	No effect
Note: TT - total thyroidectomy; pCND - prophylactic central neck dissection; Retro - retrospective; Pro - prospective; LNs - lymph nodes.

El Khatib et al., (2010) carried out a retrospective study comparing the effect of unilateral versus bilateral thymectomy in patients undergoing TT with pCND  ADDIN EN.CITE (). They showed that bilateral thymectomy significantly increased the risk of transient hypocalcaemia (p < 0.001). In addition, no benefit regarding cancer resection was observed as none of the cases had metastasis in the contralateral thymus. Only two patients had micro-metastases in lymph nodes located at the upper pole of ipsilateral thymus, but no metastasis was demonstrated within the thymic tissue itself.

2.3.4. Calcium and vitamin-D supplementation (Table 2.9.)

Calcium and vitamin D medications are usually given for the treatment of post-thyroidectomy hypocalcaemia, but have been tried as supplemental prophylactic treatment to reduce the risk of this complication. Eight studies met our inclusion criteria, and all patients had undergone TT +/- CND. Seven studies included patients with both benign and malignant thyroid disease, and one study only included patients with PTC  ADDIN EN.CITE ().

Bellantone et al., (2002) randomly assigned patients into 3 arms: one arm (control group) receiving no supplements, the second arm received oral calcium only (3g/day), and the third arm received oral calcium 3g/day + calcitriol 1 µg/day postoperatively  ADDIN EN.CITE (). They found a significantly lower risk of transient hypocalcaemia associated with postoperative supplements, but did not assess permanent hypocalcaemia.

Two other RCTs compared combined oral calcium and vitamin D supplements versus oral calcium alone  ADDIN EN.CITE (, ). One study showed significant reduced risk of transient hypocalcaemia associated with oral calcium and a high dose of vitamin D (1 µg calcitriol)  ADDIN EN.CITE (), but no effect on permanent hypocalcaemia. The other study found that combined supplementation of calcium and vitamin D decreased the risk of severe/symptomatic hypocalcaemia (not assessed transient and permanent hypocalcaemia separately)  ADDIN EN.CITE (). Meta-analysis demonstrated that combined calcium and vitamin D supplementation was associated with significant reduction in transient hypocalcemia compared to calcium supplements alone (Figure 2.6a.; OR 0.66; 95 per cent CI 0.45-0.98; P=0.04).

Table 2.9. Calcium & vitamin D replacement and effect on post-thyroidectomy hypocalcaemia
Prevention studied (number of studies)	Control arm; Study design	Transient Hypocalcaemia	Permanent Hypocalcaemia
Group B: Postop Ca 1 g TDS alone Group C: Postop Ca 1 g TDS + vit D 0.5 µg BD (N=1)	Group A: no supplements;RCT	Decreased risk 	Risk not assessed 
Group A: Postop Ca salts 500 mg TDS + 0.5 µg calcitriol BDGroup B: Postop Ca salts 500 mg TDS + 1 µg calcitriol BD (N=1)	Group C: Postop Ca salts 500 mg TDS only;RCT	Decreased risk: group B	No effect 
Postop Ca carbonate 1500 mg daily + cholecalciferol 400 IU daily (N = 1)	Postop Ca carbonate 300 mg daily;RCT	No effect 	No effect 
Preop 1 week supplements of vit D 0.5 µg TDS + thiazide diuretic 25mg OD(N=1)	No supplements/placebo;RCT	Decreased risk 	Risk not assessed 
Postop oral Ca 1g TDS + vit D 0.5 g BD(N=1)	No supplements;RCT	Decreased risk 	No effect 
Postop prophylactic Ca infusion 78-156 mg(N=1)	No Supplements;Retro cohort	Decreased risk 	Risk not assessed 
Group A: TT + CND + postop Ca 1 g TDS & alfacalcidol 0.5 µg BDGroup B: TT + CND + postop Ca 1 g TDSGroup C: TT + CND + No postop supplements(N=1)	TT + No CND + No supplements;RCT	Decreased risk: group AIncreased risk: group B & C	No effect: group A, B & C
Alfacalcidol 2 µg daily from the day before surgery to postop day 8(N=1)	No supplementsRCT	No effect 	Decreased risk 
Note: TDS – three times daily; BD – twice daily; OD – once daily; vit D – vitamin D; Ca – calcium; CND – central neck dissection; postop – post-operative; preop – pre-operative; g - gram; µg - microgram.

Roh et al., (2006) found that routine supplementation with combined oral calcium and vitamin D significantly reduced the risk of transient, but not permanent hypocalcaemia when compared to no supplementation  ADDIN EN.CITE (). Meta-analysis showed that post-operative calcium and vitamin D supplementation was associated with significantly lower rates of transient hypocalcemia compared to no supplements (Figure 2.6b.; OR 0.34; 95 per cent CI 0.15-0.75; p=0.007). 
Genser et al. (2014) randomly allocated 108 patients to no supplementation (control) and 111 patients who received 2 g of alfacalcidol daily from the day before surgery (D1) to post-operative day 8 (POD8)  ADDIN EN.CITE (). They found that routine alfacalcidol supplements significantly reduced the incidence of severe, symptomatic and permanent, but not transient hypocalcaemia.
 






Testa et al., (2006) examined the effect of a one-week preoperative administration of vitamin D with a thiazide diuretic versus no supplements/placebo  ADDIN EN.CITE (). They reported significantly lower rates of transient hypocalcaemia and shorter length of hospital stay (LOS), but did not assess permanent hypocalcaemia.
Uruno et al., (2006) carried out a prospective cohort study to assess if post-operative intravenous prophylactic calcium infusion could reduce the incidence of symptomatic hypocalcaemia  ADDIN EN.CITE (). The group receiving prophylactic calcium infusion had significantly more patients who underwent TT with CND for thyroid cancer (p = 0.022); this could represent a potential confounding factor. Patients who received prophylactic infusions had significantly lower incidence rates of post-operative numbness (p = 0.003) and tetany (p = 0.038) and higher post-operative mean serum calcium (p < 0.0001). Transient and permanent hypocalcaemia were not assessed.

Roh et al., (2009) carried out a RCT to assess the effect of postoperative supplements on rates of hypocalcaemia in a cohort of patients with PTC  ADDIN EN.CITE (). The study had patients randomized to one of 3 intervention arms: TT + CND receiving routine oral calcium and vitamin D (group A); TT + CND receiving routine oral calcium only (group B); TT + CND receiving no routine supplements (group C). These groups were compared to a control group of patients who had TT without CND and received no post-operative supplements. Combined oral calcium and vitamin D supplementation (group A) significantly reduced the rates of symptomatic and biochemical hypocalcaemia (p = 0.002 and p < 0.001 respectively). In addition, patients who received calcium alone also had significant lower rates of transient hypocalcaemia. Supplementation with combined calcium and vitamin D or calcium alone had no effect on permanent hypocalcaemia.

2.3.5. Truncal ligation of the inferior thyroid artery (Table 2.10.)

Three RCTs  ADDIN EN.CITE () and one prospective cohort study () assessed the role of ITA truncal ligation versus no truncal ligation (capsular haemostasis). All 4 studies found no association between ITA truncal ligation and transient or permanent hypocalcaemia. Meta-analysis of the three RCTs also showed no significant effects on transient (Figure 2.7a.; OR 1.09; 95 per cent CI 0.61-1.94; P=0.77) or permanent hypocalcaemia (Figure 2.7b.; OR 1.63; 95 per cent CI 0.19-13.56; P=0.65) rates.

Table 2.10. ITA ligation & PGAT and their effect on post-thyroidectomy hypocalcaemia
Prevention studied (number of studies)	Control arm; Study design	Transient Hypocalcaemia	Permanent Hypocalcaemia
Truncal ITA ligation(N=4)	No ITA ligation;RCT = 3 Pros cohort = 1	No effect: 4 	No effect: 4 
PGAT(N=3)	No PGAT;Pros cohort = 1 Retro cohort = 2	Decreased risk: 1 Increased risk: 1No effect: 1	No effect: 2Decreased risk: 1
Auto-transplantation of 2 or 3 PGs(N=1)	Auto-transplantation of 1 PG;Retro cohort	Increased risk 	No effect 
Selective ioPTH guided auto-transplantation (if ioPTH <10ng/L 10-20 min post TT)(N=1)	Elective auto-transplantation of at least 1 PG without ioPTH guidance;RCT	Decreased risk 	No effect 
Note: PG – parathyroid gland; ioPTH – intra-operative parathyroid hormone; Pros - prospective; Retro - retrospective; TT - total thyroidectomy.







2.3.6. Parathyroid gland auto-transplantation (PGAT) (Table 2.10.)

The role of PGAT in the prevention of hypocalcaemia is another debatable issue in thyroid surgery. Most surgeons would perform it only if the PGs looked ischaemic towards the end of the surgery (). Three cohort studies compared routine PGAT (suspiciously viable PG and to the surgeon discretion) versus no PGAT. Lo et al., (1998) reported prospectively significant higher risk of transient (), while Testini et al., (2007) retrospectively found a significantly lower risk of transient hypocalcaemia with routine PGAT  ADDIN EN.CITE (). Both studies found that routine PGAT had no significant effect on permanent hypocalcaemia. In contrast Ahmed et al., (2013) reported a significantly lower risk of permanent (but no effect on transient) hypocalcaemia associated with routine PGAT retrospectively ().

Abboud et al., (2008) carried out a retrospective cohort study comparing the effect of auto-transplantation of 2 or more PGs versus routine auto-transplantation of one gland  ADDIN EN.CITE (). They showed a significantly higher risk of transient (but not permanent) hypocalcaemia with auto-transplantation of two or more PGs.

Barczynski et al., (2008) performed a RCT to compare intra-operative PTH (ioPTH) guided PGAT versus elective auto-transplantation of at least 1 PG  ADDIN EN.CITE () with 170 patients in each group. They found that ioPTH-guided PGAT significantly reduced the rates of transient hypocalcaemia (p = 0.006) with no effect on permanent hypocalcaemia. 

2.3.7. Other preventative measures (Table 2.11.)
2.3.7.1. Surgical approach

Two cohort studies compared minimally invasive video-assisted thyroidectomy (MIVAT) to open TT  ADDIN EN.CITE (, ). There was no difference in the incidence of transient  ADDIN EN.CITE (, ) and permanent () hypocalcaemia between MIVAT and open TT. Del Rio et al., (2010) did not assess permanent hypocalcaemia  ADDIN EN.CITE ().

2.3.7.2. Use of magnification loupes

Testini et al., (2004) carried out a RCT to assess the benefit of using loupe magnification in patients undergoing TT (). It included patients with both benign and malignant thyroid disease. Transient and permanent hypocalcaemia were not defined. They found that the incidence of transient hypocalcaemia was 4.3 per cent with the use of loupe magnification compared to 14 per cent without. They also reported significantly shorter operative times and decreased overall morbidity with the use of magnifying loupes. Results were expressed in numbers and percentages, but no statistical tests for significance testing were reported.

Table 2.11. Other measures and their effects on post-thyroidectomy hypocalcaemia 
Prevention studied (number of studies)	Control arm; Study design	Transient Hypocalcaemia	Permanent Hypocalcaemia
Minimally Invasive Video-Assisted Thyroidectomy (MIVAT) (N=2)	Open TT;Pros cohort = 1 Retro cohort = 1	No effect: 2 	No effect: 1 Risk not assessed: 1
Preop IV infusion of Mg at induction(N=1)	No Mg infusion given;RCT	No effect	No effect
Loupe magnification (N=1)	No loupe magnification;RCT	No effect 	No effect 
Oxidized regenerated cellulose was used(N=1)	Oxidized regenerated cellulose not used;Pros cohort	No effect 	No effect 
Intra-op identification of 3-4 PGs (N=1)	Intra-operative identification of 0-2 PGs;Pros cohort	No effect	No assessed




2.3.7.3. Use of oxidized regenerated cellulose (surgicel) 

In a prospective study of 372 patients undergoing TT, Del Rio et al., (2011) examined the effect of using surgicel on the rates of hypocalcaemia  ADDIN EN.CITE (). Despite having defined transient (serum calcium <2.0 mmol/L) and permanent (persistent >12 months) hypocalcaemia, results were reported as mean postoperative calcium levels and no difference was found with the use of surgicel. 

2.3.7.4. Pre-operative intravenous magnesium infusion

Besic et al., (2008) carried out a RCT to test the effect of a pre-operative intravenous magnesium infusion in patients undergoing TT and NTT without LND (). Transient (serum calcium <2.1 mmol/L or ionized calcium <1.12 mmol/L or PTH <12 ng/L) and permanent (persistent requiring vitamin D supplements >6 months) were clearly defined. Pre-operative magnesium infusion had no significant effect on hypocalcaemia rates.

2.3.7.5. Intra-operative identification of PGs
Another prospective cohort study of 126 patients found that intra-operative identification of three or more PGs (compared to 0-2 PGs) was associated with a significantly higher rate of symptomatic (but not transient) hypocalcemia  ADDIN EN.CITE ().




Table 2.12. Summary of the effect of included measures on post-thyroidectomy hypocalcaemia
	Factors studied in Meta-analysis
	↓ risk	↑ risk	no impact
Transient hypocalcaemia	BST vs HDPost-op Ca & vit D vs Ca onlyPost-op Ca & vit D vs no supplements	None	Harmonic vs CHLigasure vs CHNTT vs TTITA truncal ligation
Permanent hypocalcaemia	None	None	Harmonic vs CHBST vs HDITA truncal ligation
	Factors studied in single RCTs and observational studies
	↓ risk	↑ risk	no impact
Transient hypocalcaemia	BiClamp device vs ligasureIpsilateral vs bilateral pCNDUnilateral vs bilateral thymectomyPre-op vit D + thiazide diuretic vs no supplementsioPTH-guided PGAT vs routine PGAT	PGAT (≥ 1 gland) vs no PGATRoutine intra-op identification of 3-4 vs 0-2 PGs	Starion TLS2 vs CHMIVATMagnifying loupesUse of surgicelPre-op IV Mg infusion
Permanent hypocalcaemia	PGAT (≥ 1 gland) vs no PGAT	Routine intra-op identification of 3-4 vs 0-2 PGs	Ligasure vs CHStarion TLS2 vs CHBiClamp device vs ligasureNTT vs TTIpsilateral vs bilateral pCNDPost-op Ca & vit D vs no supplementsPost-op Ca & vit D vs Ca onlyPre-op vit D + thiazide diuretic vs no supplementsioPTH guided PGAT vs routine PGATMIVATMagnifying loupesUse of surgicelPre-op IV Mg infusion
CH - conventional haemostasis; NTT - near total thyroidectomy; TT - total thyroidectomy; ST - subtotal thyroidectomy; HD - Hartley Dunhill; pCND - prophylactic central neck dissection; MIVAT - minimally invasive video-assisted thyroidectomy; ITA - inferior thyroid artery; ioPTH - intra-operative parathyroid hormone; IV - intravenous; Mg - magnesium; Ca - calcium; vit D - vitamin D; PG - parathyroid gland; PGAT - parathyroid gland auto-transplantation; pre-op - pre-operative; intra-op - intra-operative; post-op - post-operative; vs - versus.
2.4. Discussion

Hypocalcaemia is by far the most common complication following thyroid surgery with a significant short and long term impact on patients' health. The effectiveness of preventative measures aimed to reduce the risk of post-thyroidectomy hypocalcaemia has been evaluated in many original articles.
A recent meta-analysis of eight studies compared the use of harmonic scalpel versus ligasure in patients undergoing unilateral and bilateral thyroid surgery (). They found no significant difference between the two devices on post-operative morbidity including hypocalcemia. Another meta-analysis by Ecker et al., (2010), which included only 12 trials (all RCTs), reported significant reduction in operative time, blood loss, postoperative pain and LOS with the harmonic scalpel (versus conventional haemostasis) thus increasing its cost effectiveness ().

Haemostatic techniques: Our meta-analyses found no significant impact on either transient or permanent hypocalcemia with the use of harmonic system compared to conventional hemostasis (Figures 2.2a. and 2.2b.). In addition, ligasure did not reduce transient hypocalcemia rates, when compared to conventional hemostatic techniques (Figure 2.3.). There were more studies on the harmonic device (17 studies with 1314 patients) than for ligasure (two studies with 70 patients) that were eligible for inclusion in our meta-analyses. Funding from commercial sponsors could introduce risk of publication bias. Of the 22 studies that compared harmonic scalpel to other hemostatic techniques; 11 did not report on funding source, 10 declared no external funding source, and one declared funding by Ethicon  ADDIN EN.CITE (). Of the seven studies that compared Ligasure to other hemostatic techniques; four did not report on funding source, two declared no external funding  ADDIN EN.CITE (, ), and one  was funded by a research scholarship from the American College of Surgeons (). Therefore well-designed large RCTs are required to evaluate the effectiveness of these two devices.

Extent of surgical treatment: In recent years, surgeons have increasingly adopted TT as the operation of choice for both benign and malignant disease to reduce the risk of disease recurrence and at the same time demonstrated similar complication rates  ADDIN EN.CITE (, ). However our meta-analysis suggests that less extensive surgery is associated with lower rates of transient hypocalcaemia such as in BST versus HD (Figure 2.5a.; OR 0.35; 95 per cent CI 0.15-0.79; p=0.01). In another meta-analysis of four studies comparing ST (n=332) to TT (n=342) in patients with Graves' disease, ST was found to reduce the incidence of transient but not permanent hypocalcemia (). We do not believe that these results significantly influence the argument in favour of less extensive surgery as there is no demonstrable impact on permanent hypocalcemia. Furthermore a number of other outcomes such as risk of disease recurrence and nerve injury rates have a bearing on the decision to perform less or more radical surgery.

Papillary thyroid carcinoma usually has an excellent prognosis, and therefore prophylactic CND in patients without macroscopic evidence of lymph node disease is not routinely advocated (). Although there are no RCTs on this topic, observational evidence from included studies in this review suggests that routine pCND increases the risk of hypocalcemia. Hypocalcemia rates may be improved by reducing the extent of central neck dissection. Limiting CND to the ipsilateral central compartment  ADDIN EN.CITE (, ) or by preserving the contralateral thymus  ADDIN EN.CITE () could reduce the risk of transient (but not permanent) hypocalcemia (Table 2.8.).

Calcium and/or vitamin D supplementation: The use of prophylactic calcium and vitamin D supplementation and the nature of the supplementation regime vary considerably in clinical practice as shown in this review. Evidence from this review showed that patients who receive prophylactic calcium and/or vitamin D supplements are at a lower risk of developing transient but not permanent hypocalcemia. Some studies also postulated that routine post-operative supplementation may allow earlier and safe patient discharge  ADDIN EN.CITE (, , , ). This may be more cost-effective and facilitate the growing trend towards outpatient surgery. However this may mask true hypocalcemia rates, and lead to overtreatment in some patients, with potential for harm if supplements are continued in the long term  ADDIN EN.CITE (, ).

Alhefdhi et al. (2013) performed a meta-analysis of RCTs to assess the role of routine calcium and vitamin D supplementation in reducing the rate of symptomatic post-thyroidectomy hypocalcemia (). However they have erroneously included one prospective study  ADDIN EN.CITE () and another cohort study with a historical control (). They also included a study that compared routine to 'on demand' supplements in patients with symptomatic hypocalcemia, which represents a treatment rather than a prevention study  ADDIN EN.CITE (). Despite significant variability in patient characteristics and definitions used, they concluded that routine postoperative supplementation, particularly combined calcium and vitamin D, significantly reduced postoperative hypocalcemia. A similar meta-analysis of 4 RCTs assessed the effect of routine calcium and vitamin D on reducing the incidence of post-operative symptomatic hypocalcemia (). They reported that combined calcium and vitamin D supplements was associated with significantly lower rates of symptomatic hypocalcemia compared to either calcium alone or no supplements. The variability in the form, dose and duration of supplements used in the different studies limits the strength of evidence and the applicability of the results to clinical practice.

The authors of this review recently published a meta-analysis on predictors of post-thyroidectomy hypocalcemia where intra-operative and post-operative PTH were found to be effective predictors of transient hypocalcemia with a sensitivity ranging from 59 to 100% (). Given the relative benefits and risks of routine post-operative calcium and vitamin D supplementation, the use of intra- (or post) operative parathyroid hormone (PTH) levels to predict the risk of post-thyroidectomy hypocalcemia and guide the need for supplements in a proportion of patients appears to be a reasonable way forward. Islam et al. (2014) recently presented a management algorithm using post-operative serum PTH levels to guide the use and weaning of post-operative supplements in patients undergoing total and completion thyroidectomy ().


















3. Methylene Blue and Near Infrared fluorescence imaging of rabbit thyroid and parathyroid glands
3.1. Background
3.1.1. Properties, current use and fluorescence of Methylene Blue

Methylene Blue (MB) is a chemical compound which has various uses in many fields such as biology and chemistry. In the body, MB is rapidly reduced to leucomethylene blue  and excreted mostly as an undetermined complex salt in urine. Following oral administration, about 75% of MB is excreted in urine as leucomethylene blue, a small amount as the unchanged compound and the rest is excreted with the bile (). When administered intravenously, MB accumulates in high concentrations in the brain, which is preferable if the site of action targeted is the central nervous system (). In medicine, MB was found to be useful in the management of hypotension associated with certain clinical conditions  ADDIN EN.CITE (), and in improving hypoxia associated with liver cirrhosis and severe hepatopulmonary syndrome  ADDIN EN.CITE (). Due to strong oxidizing properties, therapeutic doses of MB, when given to patients with methaemoglobinaemia, induce methaemoglobin reductase which reduces methaemoglobin back to haemoglobin ().

MB is also a dye that localises in both thyroid and parathyroid tissue on intravenous administration with higher affinity in the latter. It has been used in parathyroid surgery since 1971 to aid the ‘naked eye’ visualisation of enlarged parathyroid glands  ADDIN EN.CITE (, ). This macroscopic visualisation is less useful in identifying ‘normal’ parathyroid glands due to decreased uptake (). The dose of MB currently used in parathyroid surgery ranges from 3mg/kg  ADDIN EN.CITE (, ) to 7.5mg/kg  ADDIN EN.CITE () depending on local practice. However, side effects are common and serious neurotoxicity has been reported, especially in patients on Selective Serotonin Reuptake Inhibitors (SSRIs), and these include: nausea, vomiting, headache, dizziness, fever, altered mental status and even encephalopathy  ADDIN EN.CITE (, , ).

MB also exhibits fluorescent properties in the near-infrared range (light outside the visible spectrum) at significantly reduced concentrations with maximum absorption of light around 670 nm (). This fluorescence detected with appropriate imaging systems using lower MB concentrations has the potential to reduce the adverse effects of MB, whilst improving the accuracy of parathyroid identification and differentiation between various tissues during neck surgery. Furthermore MB NIR fluorescence may be potentially used to map the blood supply of PGs and differences in MB uptake by these glands at the start and end of a procedure can help guide auto-transplantation of potentially damaged glands, thus reducing further the risk of postoperative hypocalcaemia and improving patients’ long-term outcomes.

3.1.2. Near-Infrared Fluorescence and Intra-operative imaging techniques in surgery

Infrared light (IR) is electromagnetic radiation with longer wavelengths than that of visible light. A wavelength is the distance over which a wave’s shape repeats, and is measured by the distance between two consecutive corresponding points of the same phase. Fluorescence is the ability of a tissues or substance to emit or reflect back a longer wavelength radiation after this tissue/substance has been excited by a shorter wavelength radiation. This emission spectrum is the range of the radiation frequencies emitted as the electrons in the excited tissue are moving back from a high energy state to a lower energy state. Fluorescent signals, emitted by the excited tissue, need appropriate imaging systems to be detected especially if they are in the invisible electromagnetic spectrum. Near-Infrared (NIR) lies in the wavelength between 700 and 2500 nm. Fibre-optic technology and image intensifiers are most sensitive to this area of the light spectrum. Also NIR range is considered better for biomedical imaging and research when compared to the ultraviolet range due to increased tissue penetration depth (millimetres to centimetres), decreased scattering and decreased absorption by tissues  ADDIN EN.CITE ().
 
NIR fluorescence imaging is a new technology that allows real-time intraoperative visualization of normal and abnormal tissues  ADDIN EN.CITE (). Tissues of interest can be stained by fluoroprobes (i.e. dyes with fluorescent properties e.g. MB and Indocyanine Green (ICG)). Fluorescence emitted by these dyes following excitation, can be detected by an appropriate imaging device. Currently, only three fluorescent contrast agents have been approved by the FDA (Food & Drug Administration in the US) for clinical use and these are: ICG (peak emission ~820 nm), MB (peak emission ~700 nm), and fluorescein (peak emission ~520 nm) (). ICG and MB are the preferred dyes for use in surgical practice as both their peak emission spectra lie within NIR range, unlike fluorescein. ICG, when compared to MB, gives a higher signal-to-background ratio (SBR) and greater luminescence (i.e. quantum yield) (). The half-life of ICG and MB is 3-5 minutes and 5-6 hours respectively. Thus the slower decay rate of MB compared to ICG renders MB a favourable dye to use offering a longer time-window to detect NIR fluorescence. Exploiting MB fluorescence, used in much lower doses rather than relying on naked eye visualisation of tissue staining, has the potential to improve surgical outcomes by early identification and preservation of PGs, while simultaneously decreasing the risks associated with high doses of MB.

The principle of real time intraoperative NIR technology is in the use of a hand-held or a mounted device to deliver energy to the tissue of interest. The same device also picks up the energy emitted back from that tissue, which appears as bright spots/light (fluorescent signals) on imaging. Using appropriate computer software, the fluorescent signals are analysed to give an estimate of fluorescence from the different tissues. This can help in the identification and differentiation of different tissue types. This technology has the potential of improving surgical outcomes by accurately assessing cancer margins  ADDIN EN.CITE (, ), normal and abnormal microvasculature  ADDIN EN.CITE () and image-guided lymph node mapping  ADDIN EN.CITE (, ). Recently, this technology has been applied in lymph node mapping in gynaecological cancer surgery  ADDIN EN.CITE () and to confirm the patency of biliary anastomoses in pancreatico-duodenal biliary surgery  ADDIN EN.CITE (). In thyroid and parathyroid surgery, this has the potential to assist in accurate identification and differentiation of the parathyroid glands from thyroid nodules and lymph nodes. This may significantly reduce the incidence of inadvertent damage and devascularisation of normal glands, thereby reducing the risk of post surgical hypoparathyroidism.

3.1.3. Available NIR technologies





SPY is a fluorescent imaging system (Figure 3.1.), mostly targeted at assessing blood supply and tissue perfusion, but can also be used to assess tumour margins and lymph node mapping (). This system allows intraoperative fluorescence angiography using ICG as a fluorophore. ICG has been applied frequently in ophthalmology, vascular and general surgery (). It has been shown to be beneficial for intraoperative assessment of perfusion and viability of flaps used in breast reconstruction surgery ().
Sood et al., (2013) carried out a retrospective study assessing the perfusion following immediate breast reconstruction using implants (). This was a retrospective case-note review study carried over two years (January 2004 to April 2006), and despite having a single-centre design they managed to include 95 consecutive patients which increased the reliability of their results. SPY technology together with surgeon’s judgement was used to assess the perfusion of the mastectomy flaps, and any regions with low signals were manoeuvred to improve the blood supply. Patients were divided into two groups, pre- and post-SPY introduction to their practice. Two patients were excluded from each arm, due to one having a flap and the other having delayed reconstruction. More complications were encountered in the pre-SPY group, but this was not statistically significant (p=0.0631). More patients in the pre-SPY group required return visits to theatre (p=0.0023). Additionally SPY technology identified significantly more ischaemic changes compared to clinical judgement alone (p<0.0001). This study demonstrates the potential benefit from using SPY technology intra-operatively in assessing tissue perfusion in various domains in surgery. SPY devices are large in size and weigh around 165 Kg (e.g. LifeCellTM).





PDE is another imaging system developed by Hamamatsu Photonics in Japan (Figure 3.2.). It has a single-band NIR camera which consequently does not allow for differentiation between auto-fluorescence and signal-to-background ratio (SBR). As the system lacks a light source, this hinders the flow of surgery (e.g. lymph node dissection) as the measurement of fluorescence requires a dark environment. PDE is a small portable device weighing 5 kg only (optical head + control box).
Tagaya et al., (2008) reported their experience using the PDE device with NIR fluorescence to identify sentinel lymph nodes (SLN) during breast cancer surgery (). They only recruited 25 consecutive patients and displayed their results in percentages accordingly, but did not perform any statistical analysis due to their small sample size. They used a mixture of two dyes, ICG and indigo carmine, and reported better fluorescence detection with the latter. Another disadvantage was the inability to include patients with iodine hypersensitivity as the commercially available indigo carmine dye contained 5% sodium iodide. Additionally the short half-life of ICG narrowed the available window for fluorescent measurement. They reported comparable SLN detection rate to patent blue which is the current standard practice. Fluorescence imaging using PDE technology allowed real-time visualisation of the lymphatic channels, which consequently guided surgeons regarding optimum skin incision in the axilla for the identification of sentinel lymph node.

Figure 3.2. PDE imaging system ()

3.1.3.3. FLARE and Mini-FLARE system

The FLARETM and the mini-FLARETM imaging systems are two systems developed by the Frangioni  Laboratory at the Beth Israel Hospital at Harvard. These two systems have been extensively used in clinical trials. The mini-FLARE system allows capturing colour video and two semi-independent channels of NIR fluorescence (700 and 800 nm) in real-time imaging  ADDIN EN.CITE (). The imaging head is attached to a flexible arm, which permits positioning of the imaging head anywhere over the surgical field and the whole imaging system weighs 12 Kg (Figure 3.3.).
Schaafsma et al., (2012) carried out a randomised controlled trial (RCT) to study the effectiveness of NIR in SLN mapping in cervical cancer  ADDIN EN.CITE (). The study was a double-blinded RCT and described clear inclusion and exclusion criteria reflecting a robust design. They recruited 18 consecutive patients, divided into 2 arms; one receiving ICG linked with human serum albumin (HSA) and the other received ICG only. Demographics, tumour characteristics and previous treatments were comparable between both groups increasing the reliability of the study. The study showed no advantage of in using ICG with HSA over ICG alone. NIR fluorescence using mini-FLARE was able to map SLNs in 14 patients (78%). 
The same research group have recently reported their experience in using the Mini-FLARE system for the identification of parathyroid adenomas (). The preliminary study recruited 12 patients with parathyroid disease (benign and malignant), and used one concentration of MB (0.5 mg/kg). Fluorescence from ‘normal’ parathyroid and thyroid tissue was not reported. They did show feasibility of identifying parathyroid adenomas using NIR fluorescence and low-dose MB and suggested correlating it with the pre-operative sestamibi scanning.





Fluobeam® is another NIR imaging system. It is a compact portable system, consisting of two components; a control box (8 kg) including all the elements to power, control and monitor the optical head (750 gm) containing a highly sensitive charge-coupled device (CCD) camera and optical elements like fibers, filters, lens and diffusers. Optical head is also the place where light emission occurs: laser and LEDs (Light Emitting Diode) (Figure 3.4.). Two imaging systems have been developed: Fluobeam®700 (Excitation wavelength 690 nm, Collected emission wavelength ≥700 nm), and Fluobeam®800 (Excitation wavelength 750 nm, Collected emission wavelength ≥800 nm). Fluobeam®700 is currently being used by the endocrine research team in Sheffield University Teaching Hospitals to develop a protocol for use in endocrine neck surgery. A phase I feasibility study for PHPT surgery in ten patients (unpublished data) has shown that Fluobeam®700 was able to pick up fluorescence in the NIR range from various soft tissue structures in the neck.

Figure 3.4. Fluobeam® imaging system ()

The following table summarizes the pros and cons of each imaging modality discussed and the reasons why we chose Fluobeam® as the imaging system of choice for our studies.




Hand-held probe	No (mounted)	Yes	Yes	No (mounted)
Light source	Yes	No	Yes	Yes
Detection of MB fluorescence	No	No	Yes	Yes

The author also carried out an animal study in six New Zealand White (NZW) rabbits using Fluobeam®700.

The aim of the in vivo experiments was to establish the pattern of MB-induced fluorescence detected by Fluobeam®700 from the soft tissue structures in the rabbit neck. The rabbit has been used as the model for in vivo study, as it has at least one visible external parathyroid gland on either side of the neck (). The specific objectives were to:
1. Determine the lowest dose of intravenous MB that allows detection of fluorescence in the neck tissues using the Fluobeam®700 system.
2. Identify time to peak fluorescence in the thyroid, parathyroid and neck strap muscle using varying doses of intravenous MB in combination with the Fluobeam®700 system.




Two New Zealand White (NZW) rabbits were obtained from Highgate Farm in Sheffield (Home Office authorised supplier), and held in the animal facility at University of Sheffield field laboratories for 3 months before experimentation. Animals were housed in a humidity- and temperature-controlled environment and allowed access to water and food ad libitum. Procedures were performed in accordance with UK Home Office Animal Procedures Act (1986), under Project License number 40/3531 (NJB). The main researcher (RA) dissected the central neck compartment of the two rabbits, following culling, to confirm their suitability as the animal model of choice for future experiments.





The central neck compartments of two rabbits were dissected at the University of Sheffield Biological Services Unit, with specific reference to the thyroid and PGs anatomy. These tissues were subject to histological confirmation. 




Details of each experiment including the rabbit characteristics, surgery, anaesthesia, MB dosage, time and duration of observation following bolus injections were recorded using a standard proforma. MB was administered as a bolus injection into the marginal ear vein at doses ranging from 0.025 mg/kg to 3 mg/kg and flushed with an infusion of normal saline. Volumes used for MB injections ranged from 0.29 ml to 2.16 ml, with varying dilutions, appropriate for an approximate circulatory volume of 56 ml/kg body weight  ADDIN EN.CITE (). NIR fluorescent images of the exposed neck soft tissues (thyroid, external parathyroid glands, and strap/skeletal muscle as control) were recorded using Fluobeam® 700 (Fluoptics, Grenoble, France), with black and white images of the operating field obtained before and after each intravenous MB bolus (Figure 3.5a. and 3.5b.). 









Oxygen saturation and heart rate were monitored throughout surgery to identify whether the circulation was compromised, which could affect MB delivery to the soft tissues of interest. At the end of each experiment, the rabbit was euthanized using IV thiopental (350 mg). Specimens from both external parathyroid glands and the thyroid were retrieved for histopathological confirmation.
Image J, a freely accessible java-based software developed by the National Institute  ADDIN EN.CITE (, ), was used for quantification of fluorescent intensity emitted from the thyroid, parathyroid and the strap muscles. Fluorescent intensities were recorded as numerical values on an Excel spreadsheet (Microsoft Office 2007), and displayed in tables and charts to demonstrate the evolution of MB fluorescence. Ratios, median values and ranges are also reported. 

3.2.4. Fluobeam Optical Imaging







Specimens were fixed in 10% buffered formalin solution at room temperature immediately following resection. Tissues were processed by ‘Leica TP1020 tissue processer’ by going through increasing concentrations of alcohol (70-100%), Xylene and wax over 22 hours. Specimens were then embedded in paraffin wax blocks and sectioned using ‘Leica 3020 microtome’ at 5 micron thickness onto ‘superfrost plus’ slides.




The characteristic features of the rabbits and the experimental protocol are presented in Table 4.2. In all rabbits, thyroid and the external PGs were initially identified by naked-eye examination; their positions marked with a surgical instrument; and subsequently confirmed by visualisation of MB fluorescence. A wide range of MB concentrations were used, with the results from the first experiment informing the dose range used in the subsequent experiment (Table 3.2.). The period of observation with each MB bolus ranged from 10 to 74 minutes in all six rabbits.
The main researcher (RA) measured the fluorescent intensity in all images taken using Image J software, processed the histology specimens and analysed the data. Findings were then correlated with the analysis done separately by Fluoptics in France to confirm the accuracy of our results. 
Table 3.2. Characteristics of rabbits used in the fluorescent imaging experiments
Rabbit	Species	Gender / Age	Weight (kg)	MB dose – period of observation	Comments
R1	NZ White	Male / 16 weeks	2.9	0.05 mg/kg for 36 minutes0.1 mg/kg for 74 minutes0.3 mg/kg for 18 minutes3 mg/kg for 11 minutes	None
R2	NZ White	Male / 16 weeks	2.9	0.025 mg/kg for 16 minutes0.05 mg/kg for 10 minutes0.1 mg/kg for 13 minutes0.3 mg/kg for 22 minutes1 mg/kg for 26 minutes	Right external PG lying over the Right thyroid lobe
R3	NZ White	Male / 16 weeks	2.8	0.05 mg/kg for 16 minutes0.1 mg/kg for 20 minutes0.3 mg/kg for 16 minutes0.6 mg/kg for 19 minutes	Right PG partially devascularised during dissection + bradycardia, hypoxia & intermittent cannula obstruction during first bolus
R4	NZ White	Male / 16 weeks	2.8	0.1 mg/kg for 28 minutes0.3 mg/kg for 23 minutes0.6 mg/kg for 14 minutes	None
R5	NZ White	Male / 16 weeks	2.8	0.3 mg/kg for 26 minutes0.6 mg/kg for 25 minutes	None
R6	NZ White-Californian	Female / 16 weeks	3.6	0.1 mg/kg for 30 minutes0.3 mg/kg for 19 minutes0.6 mg/kg for 17 minutes	None
Note: MB – Methylene Blue; PG – Parathyroid Gland.





Neck dissection performed on two rabbits demonstrated that the thyroid gland consists of 2 fleshy reddish lobes lying on either side of the upper trachea connected by a thin isthmus. Each lobe is 15-20mm in cephalo-caudal length and 6-12mm in width.  The external PGs, 3-4mm in size, were located either adjacent or inferior to the lower pole of the thyroid, deep to the strap muscles and in close proximity to the carotid sheath. This was consistent with anatomy described previously (). 









All thyroid and parathyroid glands were confirmed by histopathology examination (TJS) in H&E stained sections (Figure 3.7a. and 3.7b.). The rabbit parathyroid glands demonstrated similar morphology to human glands apart from minor differences in the proportions of the constituent cell types, the lobulation of the tissue, and the interface with the surrounding adipose connective tissue. Furthermore, MB administration had no discernible effects on the thyroid and parathyroid specimens as ascertained by routine histology.














The time to the peak fluorescence following MB administration and peak fluorescence ratios (ratio of peak fluorescence in the tissue of interest compared to fluorescence from the strap muscle measured simultaneously) in both thyroid lobes and external PGs were determined. In rabbit two, the right external PG was lying directly over the anterior surface of the right thyroid lobe which interfered with fluorescence measurements; especially after the third MB dose. In rabbit three, the right external PG was partially devascularised during neck dissection; this was reflected by the lower fluorescent intensities compared to the left external PG (Figure 3.8b.). Following anaesthetic induction, all rabbits remained physiologically stable throughout the experiments except in one case, where transient hypoxia and bradycardia were encountered during the first MB bolus, which resolved following repositioning of the endotracheal tube.
























Table 3.3. Peak fluorescence ratio of the rabbit thyroid and external parathyroid glands compared to strap muscle (control tissue) at MB doses of 0.1, 0.3 and 0.6 mg/kg
Rabbit	Peak thyroid fluorescence ratio (compared to muscle)	Peak parathyroid fluorescence ratio (compared to muscle)







Median (range)	3.5 (1.9 - 4.5)	7.475(4.4 – 10.85)	11.575(9.7 – 14.95)	1.85(1.3 – 2.1)	2.125(1.1 – 2.7)	2.2(1.25 – 2.55)

The changes in fluorescent intensities following administration of various doses of MB from thyroid, external PGs and muscle are demonstrated graphically in Figures 3.8a. to 3.8e. Very low doses of MB (0.025 and 0.05 mg/kg) were associated with minimal differences in both peak fluorescence and persistence of fluorescence between thyroid and parathyroid tissue (Figures 3.8a.). In contrast, following administration of 0.1, 0.3 and 0.6 mg/kg of MB, large differences in fluorescence intensity were observed between thyroid and parathyroid tissue. This was more pronounced at the two higher concentrations (0.3 and 0.6 mg/kg; Table 3.3. and Figures 3.8c. to 3.8e.). The time to peak fluorescence was increased for the thyroid (median 3.28 minutes, range 0.6-7.45, n=30) compared to the PGs (median 0.9 minute, range 0.6-2.5, n=29) when amalgamating data from the three MB concentrations (0.1, 0.3 and 0.6 mg/kg).

The evolution of the fluorescence signal in thyroid, parathyroid glands and muscle in rabbit six following IV injection of 0.1 mg/kg MB, is represented in Figure 3.9. This shows an obvious difference between thyroid, parathyroid and muscle fluorescence, rapid reduction in parathyroid fluorescence, and the persistence of fluorescence in the thyroid. Further differential enhancement was not achieved with higher MB doses.







To our knowledge, this is the first study to examine the patterns of near infra-red (NIR) fluorescence induced by administration of systemic MB in normal thyroid and parathyroid tissue in an in vivo model. NIR wavelength (500-700 nm) is considered the most appropriate optical range to use in biomedical research due to increased penetration depth, decreased scattering and tissue absorption compared to the ultraviolet light range (10-400 nm)  ADDIN EN.CITE (). MB administered at 0.1 mg/kg was the lowest concentration which clearly demonstrated difference in fluorescence from the soft tissues of interest in the rabbit neck. This dose is 1/30th of the dose currently used in clinical practice to aid the naked-eye visualisation of diseased parathyroid glands.

The aim of the study was to evaluate the onset, time to peak and duration of fluorescence from thyroid and parathyroid glands using a range of MB concentrations. Understanding the fluorescence patterns and kinetics in the rabbit model will guide further clinical studies to determine whether lower MB concentrations differentiate between the structures of interest during thyroid and parathyroid surgery. This has the potential to decrease the morbidity associated with MB administration and improve patient outcomes.

Van der Vorst el al., (2013) used an imaging system (Mini-FLARE 700 nm wavelength) similar to the one in the current study and demonstrated the feasibility of MB NIR in guiding intra-operative identification of parathyroid adenomas in human surgery ().  They used a single concentration of MB (0.5 mg/kg) in 12 patients with parathyroid disease (benign and malignant). However fluorescence emission from ‘normal’ parathyroid and thyroid tissue was not reported. The study concluded that NIR fluorescence from low-dose MB can be used to identify parathyroid adenomas.

The current 'proof of concept' study using a relatively small number of rabbits demonstrated a clear distinction in fluorescence between the normal thyroid and parathyroid tissues. Although a MB dose-response approach was utilised in each animal, sufficient time elapsed between each consecutive dose. This allowed the fluorescence to decay to near baseline values, thus limiting the impact of any cumulative fluorescence. Regardless of the starting MB dose, clear differentiation between the pattern of parathyroid and thyroid fluorescence were noted with doses of 0.1, 0.3 and 0.6 mg/kg body weight. The study also identified that overlapping thyroid and parathyroid tissue may distort the results, so it will be important in future studies to separate the tissues whenever possible, which could represent a challenge in human surgery. Although the results cannot be directly extrapolated to humans, the technology shows potential to facilitate early identification and preservation of extra-thyroidal parathyroid glands.









4. Electrical Impedance Spectroscopy (EIS) of Rabbit Thyroid and PGs

4.1. Background
Thyroid surgery is the most widely performed endocrine surgical procedure (). Complications of thyroid surgery include hypocalcaemia, recurrent laryngeal nerve (RLN) injury, infection and bleeding  ADDIN EN.CITE (). Hypocalcaemia is the most common complication following bilateral thyroid surgery and can occasionally be permanent. The reported incidence rates for transient and permanent hypocalcaemia after bilateral thyroid surgery range from 5 to 35%  ADDIN EN.CITE () and 0.5 to 12%  ADDIN EN.CITE (, ) respectively.

Acute hypocalcaemia may manifest as circumoral paraesthesia, tetany, carpopedal spasm, laryngospasm, ECG changes and cardiac arrest in severe cases (). Management of hypocalcaemia requires replacement therapy with calcium and vitamin D supplements  ADDIN EN.CITE () and close biochemical monitoring  ADDIN EN.CITE ().  In the long-term, these patients have higher risk of chronic renal impairment, basal ganglia calcification  ADDIN EN.CITE () and reduced quality of life ().

Inadvertent damage to the parathyroid glands and/or their vascular supply is the most common cause of postoperative hypocalcaemia (). This is partly due to the inability to identify and preserve normal glands during thyroid surgery. Parathyroids glands (PGs) are usually four in number (two on either side of the thyroid gland) and around 3-5 mm in size. Their number and location may vary considerably  ADDIN EN.CITE (, ) and they are often difficult to distinguish from adjacent thyroid nodules, lobules of fat and lymph nodes.

Electrical impedance (EI) is the measure of resistance that a circuit (​http:​/​​/​en.wikipedia.org​/​wiki​/​Electrical_circuit" \o "Electrical circuit​) (or intervening tissue or material) poses to an alternating current (​http:​/​​/​en.wikipedia.org​/​wiki​/​Alternating_current" \o "Alternating current​) when voltage (​http:​/​​/​en.wikipedia.org​/​wiki​/​Voltage" \o "Voltage​) is applied. Differences in how cells are layered in a tissue, cellular constituents including lipid content and nuclear size can affect electrical impedance. The effect of these differences on impedance also vary across a range of frequencies (). The thyroid gland is composed mostly of follicles that store thyroglobulin, lined by a single layer of epithelial cells with calcitonin secreting parafollicular cells scattered between follicles; while PGs are composed of densely packed chief and oxyphil cells. Ion mobility and therefore electrical impedance is also temperature-dependent as it is closely related to temperature-induced fluid and electrolytes shifts within tissues (). As temperature drops, tissue impedance rises by about 2% per °C  ADDIN EN.CITE ().

In human prostate tissue, electrical impedance spectroscopy (EIS) demonstrated different electrical impedance patterns in normal and malignant tissues; this has potential to improve the accuracy of prostate cancer diagnosis  ADDIN EN.CITE (, ). Kerner et al., (2002) compared a visual criterion to a numerical method in assessing breast lesions on EIS images against the American College of Radiology (ACR) ranking system in 51 mammograms  ADDIN EN.CITE (). The visual criterion was able to detect more suspicious lesions (ACR 4-5) and more normal breasts (ACR1) compared to the numerical method, 83% and 79% versus 67% and 66% respectively. Another study, showed EIS to have higher sensitivity and specificity in differentiating between malignant melanoma, non-malignant melanoma and benign skin naevi compared to the traditional visual screening used by general practitioners  ADDIN EN.CITE (). EIS was also used to study the evolution of ischaemic changes over time in myocardial and liver tissue (). In a study on 474 women using EIS to detect high-grade cervical intraepithelial neoplasia (HG-CIN), EIS increased the positive predictive value (PPV) of colposcopy in diagnosing HG-CIN from 53.5% to 67%  ADDIN EN.CITE ().
Hypothesis:
The electrical impedance spectra across a range of frequencies are different between various soft tissues of the neck, including thyroid, parathyroid glands, adipose and skeletal muscle.
Aims:
The aims of this animal experiment were to:
1. Establish the patterns of electrical impedance in rabbit thyroid, parathyroid, adipose tissue and skeletal muscle in in vivo (in situ) and ex vivo conditions using the APX100TM EIS device.









Each rabbit had one ureter tied 2 weeks prior and the relevant kidney extracted under general anaesthesia for an unrelated research project studying the effects of renal fibrosis; then culled by exsanguination from a major vessel (aorta). The ventral aspect of the neck was then immediately dissected via a vertical incision exposing the central compartment where the thyroid and external (extra-thyroidal) parathyroid glands were identified.




The APX100TM EIS device (Figure 4.1.) is a cordless device developed by Zilico and consists of a hand-held unit, a base station for downloading data to a laptop, a disposable single-use sheath covering the nozzle of the hand-held unit and associated software. The 5.5 mm diameter tip of the nozzle is placed in contact with the tissue. This tip has four gold electrodes, the diameter and spacing of which determine the flow of current into the tissue. A four-electrode current transfer and impedance measurement is made as described previously  ADDIN EN.CITE (). In brief, the current (<12 µA p–p) is passed between an adjacent pair of electrodes, and impedance is measured between the remaining pair. Each measurement is done at 14 different frequencies (ranging from 76 to 625000 Hz) in around 20 milliseconds. After taking the measurements, the data is downloaded to a laptop computer  and transformed into a measure of mean EI and standard deviation at each frequency.

Figure 4.1. APXTM Electrical Impedance device (developed by Zilico)
 






Specimens were fixed in 10% buffered formalin solution at room temperature following ex vivo measurements. Tissues were processed using a ‘Leica TP1020 tissue processer’ passing through increasing concentrations of alcohol (70-100%), Xylene and wax over 22 hours. Specimens were then embedded in paraffin wax blocks and sectioned using a ‘Leica 3020 microtome’ at 5 micron thickness onto ‘superfrost plus’ slides.
Slides were stained using haematoxylin and eosin (H&E) staining using the following technique: Sections were dewaxed in Xylene and taken to water through descending concentrations of alcohol. Aqueous Gill’s haematoxylin stain was applied for 1-2 minutes; followed by 5 minutes wash in tap water. Slides were then subject to increasing alcohol concentrations (70 to 95% ethanol), stained with eosin in 95% ethanol for 1 minute, and then treated with 100% ethanol (1 minute) and Xylene (2 x 5 minutes). Sections were then mounted in DPX (distyrene, a plasticizer, and Xylene) and coverslip.











The characteristics of the rabbits and the experimental conditions are summarized in Table 4.1. 
Table 4.1. General characteristics of the rabbits and EI experimental conditions
Rabbit	Species	Gender / Age	Weight (kg)	in vivo / ex vivo temperatures	Time difference between in vivo and ex vivo measurements
R1	NZ White	Female / 14 weeks	3.2	28.6 °C / 18.4 °C	22 minutes
R2	NZ White	Female / 14 weeks	3.2	29.6 °C / 15.1 °C	22 minutes
R3	NZ White	Female / 14 weeks	3.2	30.0 °C / 15.2 °C	17 minutes
R4	NZ White	Female / 12 weeks	3.12	31.6 °C / 16.2 °C	18 minutes
R5	NZ White	Female / 12 weeks	3.12	28.2 °C / 17.6 °C	24 minutes
R6	NZ White	Female / 15 weeks	3.3	30.5 °C / 12.0 °C	23 minutes
R7	NZ White	Female / 15 weeks	3.5	29.6 °C / 13.9 °C	24 minutes
R8	NZ White	Female / 13 weeks	3.28	29.9 °C / 13.5 °C	26 minutes
R9	NZ White	Female / 13 weeks	3.28	28.0 °C / 16.2 °C	20 minutes

In situ EI measurements were obtained were obtained within 10-40 minutes of culling. All thyroid and external parathyroid glands identified for impedance measurements were confirmed to be normal on histological examination i.e. unaffected by the unilateral renal fibrosis (Figures 4.2. and 4.3.). There were no changes suggestive of hyperplasia or adenoma in the parathyroid glands examined. In situ and ex vivo temperatures ranged from 28.0 to 31.6 °C and 12.0 to 18.4 °C respectively.











In vivo and ex vivo EIS measurements were successfully obtained from both thyroid lobes (upper and lower surface) in all nine rabbits. Muscle EIS measurements were also obtained in all animals except on two occasions in the ex vivo setting. Impedance measurements could not be obtained from some parathyroid glands, due to their small size (not covering the whole tip of the APX100). This occurred on 3 occasions in the in vivo setting and on 15 occasions in the ex vivo setting. Measurements could not be obtained from adipose tissue; this is most likely due to very high impedance.

The median EI spectra of thyroid, parathyroid and muscle tissue in vivo across a range of frequencies are illustrated in Figure 4.4. The median EI spectra for thyroid and parathyroid tissue in in vivo and ex vivo conditions are demonstrated in Figures 4.5. and 4.6. respectively. 












Figure 4.6. Parathyroid in situ and ex vivo median electrical impedance (15 spectra) across a range of frequencies (76 to 625000 Hz).











To our knowledge, this is the first study to examine electrical impedance spectra of thyroid and parathyroid glands. Electrical impedance of the thyroid gland was significantly higher than that of the parathyroid glands at the lower range of frequencies. This could be explained by the loose cellular arrangement in follicles (for storing thyroglobulin). On the other hand, the parathyroid glands consisting of densely arranged cells; had relatively higher impedance than thyroid tissue at the higher range of frequencies. The study of EI of other soft tissue structures such as lymph nodes and the recurrent laryngeal nerve was not possible as a minimum tissue width of 5.5 mm to adequately cover the tip of the APX100 device to be able to measure electrical impedance.

The drop in temperature between in situ and ex vivo conditions accounted for the higher impedance readings across all frequencies in all tissues  ADDIN EN.CITE (, , ). However this was kept to a minimum by obtaining the in situ EIS measurements within 10-40 minutes of culling (10 minutes in 3 animals, 15 minutes in 1, 20 minutes in 3, 30 minutes in 1 and 40 minutes in 1) and by placing the animal on a heat pad while dissecting to minimise heat loss even further. Understanding the changes in impedance with temperature would be essential to predict the nature of a specimen immediately after excision in settings where frozen section facilities are not available. It may also help in the detection of gland ischaemia and guide the decision to auto-transplant ischaemic parathyroid glands intraoperatively.




We acknowledge that simple identification of parathyroid tissue may not be sufficient to prevent hypoparathyroidism. To study if temperature changes induced by ischaemia in an in situ / in vivo gland causes changes in impedance, measurements need to be made during live animal or human dissections. This alongside EI measurements from lymph nodes and adipose tissue is planned in the proposed human study as well as studying the impedance patterns of diseased thyroid and PGs. Furthermore in the planned human study, PGs will need to be identified separately. However, EIS can potentially aid in the identification/confirmation of these glands in equivocal cases.

This study was done alongside another research project on rabbits and therefore had to be performed in freshly culled rather than anaesthetised animals. This is in accordance with the "3 Rs" principle "Replacement, Reduction and Refinement" of the use of animals in research according to the Universities Federation for Animal Welfare (UFAW) in 1954. The small size of rabbit parathyroid glands did not allow the acquisition of EI readings from  some of the glands, however this technical difficulty may be less of an issue in human surgery. We acknowledge that ensuring the same pressure was applied while obtaining all EI measurements is a subjective technique. To keep the measurements as homogenous as possible, all experiments and measurements were carried out by the same investigator who was trained on how best to use the APX100 device.

Acknowledgement: We thank the renal research team at the University of Sheffield for allowing us to perform our experiments on their freshly culled rabbits, and Mrs Maggie Glover for preparing the H&E histology slides.


5. Discussion and Future work
5.1. Discussion 

Our comprehensive hypocalcaemia prevention systematic review identified routine post-operative calcium and/or vitamin D supplementation and BST versus HD procedure to be effective measures in reducing the risk of post-thyroidectomy transient hypocalcaemia. We also identified the need for consensus guidelines for defining and assessing transient and permanent hypocalcaemia in order to increase the strength and generalisability of future research in this field. No measures were found to be significantly associated with a lower risk of permanent hypocalcaemia. However this needs to be further assessed in large multicentre RCTs due to low incidence of permanent hypocalcaemia.

The animal studies confirm that novel non-invasive modalities such as fluorescence imaging and electrical impedance spectroscopy can differentiate between the following soft tissues; thyroid, parathyroid and skeletal muscle. Additionally, NIR fluorescence using MB, as shown in the live rabbit experiments, has the ability to delineate the blood supply to external PGs, which could represent a useful new intra-operative tool for assessing vascular integrity of PGs during human surgery.

Based on these results, human trials are currently underway to assess the applicability of these new modalities during neck surgery. This has the potential to improve not only patients' outcomes, but also the techniques with which endocrine/neck surgery is currently being performed. Furthermore, with the continuous development and refinement of technologies and devices, the limitations met during our experiments could possibly be eliminated or reduced, which would potentially increase the applicability of these devices.

5.2. Future work
5.2.1. Near Infrared fluorescence imaging in human thyroid and parathyroid surgery

This phase Ib trial is currently underway at the Royal Hallamshire Hospital, the tertiary endocrine referral centre at Sheffield University Teaching Hospitals (STH17176). The aim of this trial is to develop a protocol for the use of Fluobeam® with intravenous MB in the detection of parathyroid tissue and its differentiation from adjacent soft tissue during human thyroid and parathyroid surgery. It aims to optimise the dose and timing of administration of MB, familiarise the surgical team with the use of the Fluobeam® device. The study included all patients aged 18 years old who undergoing total thyroidectomy or bilateral neck exploration for PHPT. The study will be carried out in three stages; ‘training’, ‘testing’ and ‘final’ stages to guide the decision making process for dosing and to focus the study accordingly with an overall aim of enrolment limit of 50 patients.
The testing phase aimed to optimize the protocol and hone into a single dose to be used in the final phase, which will provide preliminary data for a Phase II multicentre randomized controlled study. Thyroid and parathyroid patients have been included to ensure a range of both normal and abnormal glands as the uptake and retention of methylene blue may differ across pathologies.

Preliminary results so far have shown that in parathyroid adenomas, the parathyroid gland fluoresces significantly brighter than the thyroid and for longer. At 0.4mg/kg, the parathyroid gland was still at maximum fluorescence at 10 minutes in one patient. Therefore a dose of 0.4mg/kg has been chosen for the final stage of the study as at this dose there seems to be a consistent difference in the fluorescence of the glands with the parathyroid fluorescing brighter. Parathyroid auto-fluorescence has also been noted prior to the injection of MB. In one patient where the parathyroid was devascularised, the fluorescence of the gland did not change. Hence although it was visible with auto-fluorescence, it was clear that its blood supply was compromised after giving the MB. In two patients, one gland was identified and the MB was given to study that gland and then a second gland became apparent on the screen.
No participants developed symptomatic hypocalcaemia. However, two patients were treated for biochemical hypocalcaemia. Both patients underwent total thyroidectomy for Graves’ disease. The second patient’s histology revealed an excised subcapsular embedded parathyroid gland within the right lobe of the thyroid. The Fluobeam® camera had been used to record the left side of the neck.
 5.2.2. Electrical impedance spectroscopy (EIS) in thyroid and parathyroid surgery

Based on our findings from the animal experiments, a trial to investigate the role of EIS in intra-operative identification and differentiation between thyroid, PGs, lymph nodes, adipose tissue and skeletal muscle during neck surgery will start recruiting patients in July 2016 once the clinical NIR study has been completed. The newer device model "ZedScanTM" is planned to be used in this trial. A current limitation with the use of this device is that the sensors are currently not sterilized and ready for use in human surgery. The electrical and microbiological properties of the sensors have been tested following subjecting the sensor tips to a variety of sterilization methods. A series of experiments have been conducted by Synergy Health to determine the appropriate sterilisation procedure for the sensor tips both to ensure patient safety and effective measurement of impedance.
This is a phase I, prospective, observational study. The study will include patients undergoing thyroid and parathyroid surgery and will evaluate the EI of thyroid, parathyroid, fat, lymph nodes and strap muscles at a range of frequencies. This will enable the development of a protocol for the use of the ZedScanTM in routine thyroid and parathyroid surgery.

This study aims to:
1. Assess the feasibility and utility of EIS as an intra-operative imaging tool in clinical practice 
2. Determine the EI of various tissues of interest (both normal and diseased) during surgery on the central neck compartment and examine differential patterns between these tissues
3. Investigate changes in EI before and immediately after excision of soft tissue structures in thyroid and parathyroid surgery (assess the effects of in vivo devascularisation of thyroid and PGs)




5.2.3. Confocal Microscopy in endocrine and breast surgery

Confocal reflectance microscopy (CRM) is a non-invasive imaging modality that can provide optical sectioning of a tissue either in its native in vivo or freshly excised ex vivo form  ADDIN EN.CITE (). The technique involves the use of a small portable imaging device to map the surface of a tissue and then reflects/produces an image of that scanned surface tissue similar to a histology section. This does not require the use or injection of any additional dyes or substances and is therefore unlikely to influence the nature of the operation or the outcomes. The main advantage of this technology is that imaging is achieved without the need for fixation, processing or staining that is otherwise required for conventional histopathology examination  ADDIN EN.CITE ().
CRM has been recently applied with varying degrees of success in the fields of dermatology, breast and upper gastrointestinal surgery. It has shown to be a useful tool in assessing the cancer margins of lentigo maligna and basal cell carcinoma lesions, and subsequently guiding further surgical management  ADDIN EN.CITE (). It has also been shown to be a useful tool in the identification of Paget's disease in the breast  ADDIN EN.CITE ().






Spectroscopy is the study of the interaction between substance and electromagnetic radiation. It relates to the measurement of radiation intensity, wavelength frequency, energy/colour emission resulting from this interaction. Various types of spectroscopy are being used in the field of medical research and can be classified according to the type of the energy used into:
1- Electromagnetic radiation e.g. microwave, terahertz, infrared, near infrared, ultraviolet, gamma and x-ray spectroscopy.
2- de Broglie wavelength which studies, at the atomic level of a substance, the kinetic energy and resonant interaction between electrons and neutrons following excitation.
3- Acoustic spectroscopy which involves the use of pressure waves.

Spectroscopy can also be described according to the nature of interaction between the energy used and the substance into:
- Absorption spectroscopy e.g. infrared gas analysers used to identify presence of pollutants in the air
- Emission as in fluorescence studies
- Impedance i.e. the ability of a substance to impede or slow the transmittance of energy 
- Scattering e.g. Raman Spectroscopy
- Reflection spectroscopy e.g. confocal reflectance microscopy
- Resonance e.g. Nuclear Magnetic Resonance (NMR) spectroscopy used to determine a compound unique structure

A number of the above technologies have been used with success as intraoperative adjuncts.
Near-infrared (NIR) spectroscopy has been used for the continuous monitoring of oxygen saturation to assess compromised lower limb perfusion during cardiac surgery and guide further management accordingly (). NIR spectroscopy has also been used to assess regional oxygen saturation in the remnant stomach (following previous gastrectomy) in two patients undergoing pancreatectomy and helped preserve the remnant stomach  ADDIN EN.CITE (). Fluorescence spectroscopy , in the field of neurosurgery, has been used to safely guide the maximum safe resection of glioblastoms  ADDIN EN.CITE (). Similarly Raman spectroscopy has shown to have a high specificity and sensitivity of 73% and 86% respectively in differentiating between normal and invasive brain cells during brain cancer surgery (). Diffuse reflectance spectroscopy allowed accurate quantification of thermal tissue damage during and after radiofrequency ablation for non-resectable colorectal liver metastases  ADDIN EN.CITE (). In the field of endocrine surgery, NMR spectroscopy was shown to be a reliable and fast technique in differentiating between single and multi-glandular disease in patients with PHPT  ADDIN EN.CITE ().


5.2.5. Further RCTs of existing technologies and collaboration between centres

Prophylactic oral calcium and vitamin D supplementation has been identified in our meta-analysis as a significant preventative measure against post-thyroidectomy hypocalcaemia. Due to the variety of in the definitions and the measures currently used to diagnose hypocalcaemia, this needs to be further assessed in a large, multi-centred randomised controlled setting.

The proposed RCT would recruit patients undergoing bilateral thyroid and parathyroid surgery. The aim would be to recruit 100 patients in each centre (according to a set of inclusion and exclusion criteria), and depending on the numbers of patients recruited, it would be carried out over a two-year period. The study aim would be to assess the safety and effectiveness of a specific regime of vitamin D and/or calcium oral supplementation in reducing the risk of postoperative hypocalcaemia compared to a controlled group who will be given a placebo.
Patient groups, such as Butterfly Thyroid Cancer Trust, Hypoparathyroidism UK and British Thyroid Foundation, will be invited to help provide information leaflets and support to the patients during the trial.
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